745 genotypes with 883 annotations displayed
of selected term and subterms
|
Searched Term: abnormal behavioral response to xenobiotic
|
A4galttm1Kfk/A4galttm1Kfk
(involves: C57BL/6)
|
impaired behavioral response to xenobiotic
|
J:108352
|
Aaq1C57BL/6J/Aaq1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal alcohol consumption
|
J:43654
|
Aaq1C57BL/6J/Aaq1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal alcohol consumption
|
J:43654
|
Abtb3tm1c(EUCOMM)Wtsi/Abtb3tm1c(EUCOMM)Wtsi Slc32a1tm2(cre)Lowl/Slc32a1+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
enhanced behavioral response to xenobiotic
|
J:337062
|
Actre1C57BL/6J/Actre1C57BL/6J
(involves: BALB/cJ * C57BL/6J * DBA/2J * LP/J)
|
hyperactivity elicited by ethanol administration
|
J:116204
|
Actre1C57BL/6J/Actre1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
hyperactivity elicited by ethanol administration
|
J:84713
|
Actre1DBA/2J/Actre1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
hyperactivity elicited by ethanol administration
|
J:84713
|
Actre2C57BL/6J/?
(involves: BALB/cJ * C57BL/6J * DBA/2J * LP/J)
|
hyperactivity elicited by ethanol administration
|
J:116204
|
Actre2C57BL/6J/Actre2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
hyperactivity elicited by ethanol administration
|
J:71081
|
Actre2C57BL/6J/Actre2C57BL/6J
(involves: A/J * AKR/J * BALB/cJ * C3H/HeJ * C57BL/6J * CBA/2J * DBA/2J * LP/J)
|
hyperactivity elicited by ethanol administration
|
J:71081
|
Actre5BALB/cJ/?
(involves: BALB/cJ * C57BL/6J * DBA/2J * LP/J)
|
hyperactivity elicited by ethanol administration
|
J:116204
|
Adamts4tm1Dgen/Adamts4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Adcy5tm1Plhn/Adcy5tm1Plhn
(involves: 129S4/SvJae * C57BL/6J)
|
impaired behavioral response to xenobiotic
|
J:79146
|
Adgrl3Gt(S17-5H1)Sor/Adgrl3Gt(S17-5H1)Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
enhanced behavioral response to cocaine
|
J:185872
|
Adh1tm1Gdu/Adh1tm1Gdu
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
enhanced behavioral response to alcohol
|
J:55555
|
Adh7tm1Gdu/Adh7+
(B6.129(Cg)-Adh7tm1Gdu)
|
enhanced behavioral response to xenobiotic
|
J:167234
|
Adh7tm1Gdu/Adh7tm1Gdu
(B6.129(Cg)-Adh7tm1Gdu)
|
enhanced behavioral response to xenobiotic
|
J:167234
|
Adktm2Bois/Adktm2Bois Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
increased susceptibility to pharmacologically induced seizures
|
J:237189
|
Adora2atm1Dyj/Adora2atm1.1Dyj Tg(Camk2a-cre)1Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
impaired behavioral response to addictive substance
|
J:104338
|
Adora2atm1Jfc/Adora2atm1Jfc
(involves: 129S4/SvJae * C57BL/6)
|
impaired behavioral response to addictive substance
|
J:99612,
J:107988
|
Adora2atm1Jfc/Adora2atm1Jfc
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
impaired behavioral response to addictive substance
|
J:106215,
J:107988
|
Adora2atm1Map/Adora2atm1Map
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
impaired behavioral response to alcohol
|
J:97386
|
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J)
|
impaired behavioral response to addictive substance
|
J:76004
|
Adra1dtm1Jabl/Adra1dtm1Jabl
(involves: 129S6/SvEvTac)
|
impaired behavioral response to addictive substance
|
J:103966
|
Aifm1Hq/Y
(B6CBACa Aw-J/A-Aifm1Hq/J)
|
abnormal seizure response to pharmacological agent
|
J:98103
|
Aifm1Hq/Aifm1Hq
(B6CBACa Aw-J/A-Aifm1Hq/J)
|
abnormal seizure response to pharmacological agent
|
J:98103
|
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6 * FVB/N)
|
decreased susceptibility to pharmacologically induced seizures
|
J:138972
|
Akt3Nmf350/Akt3+
(C57BL/6J-Akt3Nmf350)
|
increased susceptibility to pharmacologically induced seizures
|
J:169028
|
Akt3Nmf350/Akt3Nmf350
(C57BL/6J-Akt3Nmf350)
|
increased susceptibility to pharmacologically induced seizures
|
J:169028
|
Alcdp1DBA/2J/Alcdp1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased behavioral withdrawal response
|
J:91457
|
Alcdp2C57BL/6J/Alcdp2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased behavioral withdrawal response
|
J:91457
|
Alcdp2DBA/2J/Alcdp2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased behavioral withdrawal response
|
J:91457
|
Alcp1C57BL/6J/Alcp1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal alcohol consumption
|
J:33277
|
Alcp1DBA/2J/Alcp1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:94343
|
Alcp2C57BL/6J/Alcp2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
increased alcohol consumption
|
J:33277
|
Alcp3C57BL/6J/Alcp3C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:52086
|
Alcp3C57BL/6J/Alcp3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:52086
|
Alcp3DBA/2J/Alcp3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:52086
|
Alcp4C57BL/6J/Alcp4C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:56967
|
Alcp4C57BL/6J/Alcp4DBA/2J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:56967
|
Alcp4DBA/2J/Alcp4DBA/2J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:56967
|
Alcp19A/J/?
(involves: A/J * C57BL/6J)
|
abnormal alcohol consumption
|
J:52467
|
Alcp25C57BL/6Ibg/Alcp25C57BL/6Ibg
(involves: C57BL/6Ibg * DBA/2Ibg)
|
alcohol preference
|
J:56967
|
Alcp25DBA/2Ibg/Alcp25C57BL/6Ibg
(involves: C57BL/6Ibg * DBA/2Ibg)
|
alcohol preference
|
J:56967
|
Alcp25DBA/2Ibg/Alcp25DBA/2Ibg
(involves: C57BL/6Ibg * DBA/2Ibg)
|
alcohol preference
|
J:56967
|
Alcp26C57BL/6Ibg/Alcp26C57BL/6Ibg
(involves: C57BL/6Ibg * DBA/2Ibg)
|
alcohol preference
|
J:56967
|
Alcp26DBA/2Ibg/Alcp26C57BL/6Ibg
(involves: C57BL/6Ibg * DBA/2Ibg)
|
alcohol preference
|
J:56967
|
Alcp26DBA/2Ibg/Alcp26DBA/2Ibg
(involves: C57BL/6Ibg * DBA/2Ibg)
|
alcohol preference
|
J:56967
|
Alcw1C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
impaired behavioral response to alcohol
|
J:56967
|
Alcw1DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to alcohol
|
J:56967
|
Alcw2C57BL/6J/Alcw2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
decreased behavioral withdrawal response
|
J:76251,
J:88800
|
Alcw2C57BL/6J/Alcw2C57BL/6J
(D2.B6-Alcw2C57BL/6J)
|
decreased behavioral withdrawal response
|
J:143371
|
impaired behavioral response to alcohol
|
J:143371
|
Alcw2DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased behavioral withdrawal response
|
J:88800,
J:36168
|
Alcw3C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to alcohol
|
J:36168
|
Alcw3DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
impaired behavioral response to alcohol
|
J:36168
|
Alcw4C57BL/6J/Alcw4C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to alcohol
|
J:40120
|
Alcw4DBA/2J/Alcw4DBA/2J
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to alcohol
|
J:40120
|
Aldh2Gt(OST7285)Lex/Aldh2Gt(OST7285)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased alcohol consumption
|
J:152060
|
enhanced behavioral response to alcohol
|
J:152060
|
Aldh2tm1.1Mak/Aldh2+
(involves: 129S6/SvEvTac * C57BL/6J)
|
enhanced behavioral response to alcohol
|
J:223796
|
Aldh2tm1.1Mak/Aldh2tm1.1Mak
(involves: 129S6/SvEvTac * C57BL/6J)
|
enhanced behavioral response to alcohol
|
J:223796
|
Alg13em1Bayu/Y
(involves: C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:275180
|
Alktm1Swm/Alktm1Swm
(involves: 129P2/OlaHsd * C57BL/6J)
|
enhanced behavioral response to alcohol
|
J:227538
|
increased alcohol consumption
|
J:227538
|
AlprfBALB/cJ/AlprfBALB/cJ
(involves: BALB/cJ * C57BL/6ByJ)
|
alcohol preference
|
J:66465
|
Amphtm1Pdc/Amphtm1Pdc
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:75306
|
Anks1btm1b(KOMP)Wtsi/Anks1btm1b(KOMP)Wtsi
(B6(FVB)-Anks1btm1b(KOMP)Wtsi)
|
enhanced behavioral response to xenobiotic
|
J:240601
|
Ap1qC57BL/6J/Ap1qC57BL/6J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:49707
|
Ap1qC57BL/6J/Ap1qDBA/2J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:49707
|
Ap2qC57BL/6J/Ap2qC57BL/6J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:49707
|
Ap2qC57BL/6J/Ap2qC57BL/6J Ap6qC57BL/6J/Ap6qC57BL/6J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:71165
|
Ap3m2tm1Ohno/Ap3m2tm1Ohno
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:93312
|
Ap3qC57BL/6J/Ap3qC57BL/6J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:49707
|
Ap3qC57BL/6J/Ap3qDBA/2J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:49707
|
Ap4qC57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:49707
|
Ap5qC57BL/6J/Ap5qC57BL/6J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:49707
|
Ap5qC57BL/6J/Ap5qDBA/2J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:49707
|
Ap6qC57BL/6J/Ap6qC57BL/6J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:49707
|
Ap6qC57BL/6J/Ap6qDBA/2J
(involves: C57BL/6J * DBA/2J)
|
alcohol preference
|
J:49707
|
Ap7q129P3/J/Ap7qC57BL/6ByJ
(involves: 129P3/J * C57BL/6ByJ)
|
abnormal alcohol consumption
|
J:78215
|
Ap7qC57BL/6ByJ/Ap7qC57BL/6ByJ
(involves: 129P3/J * C57BL/6ByJ)
|
abnormal alcohol consumption
|
J:78215
|
Ap8q129P3/J/Ap8qC57BL/6ByJ
(involves: 129P3/J * C57BL/6ByJ)
|
abnormal alcohol consumption
|
J:78215
|
alcohol preference
|
J:78215
|
Ap8qC57BL/6ByJ/Ap8qC57BL/6ByJ
(C57BL/6ByJ)
|
abnormal alcohol consumption
|
J:78215
|
alcohol preference
|
J:78215
|
Apba1tm1Amor/Apba1tm1Amor
(involves: 129 * C57BL/6J)
|
impaired behavioral response to addictive substance
|
J:102794
|
Aqp4tm1Gghu/Aqp4tm1Gghu
(involves: 129P2/OlaHsd * C57BL/6J)
|
impaired behavioral response to cocaine
|
J:111202
|
Arhgap32tm1Taki/Arhgap32tm1Taki
(B6N.Cg-Arhgap32tm1Taki)
|
increased susceptibility to pharmacologically induced seizures
|
J:236753
|
Arxtm3Kki/Y
(involves: 129S/SvEv * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:152416
|
Atp1a1tm1Ling/Atp1a1+
(involves: 129P2/OlaHsd * Black Swiss)
|
enhanced behavioral response to addictive substance
|
J:117414
|
Atp1a3Myk/Atp1a3+
(B6NCr.129S1-Atp1a3Myk)
|
abnormal sensitization to xenobiotic
|
J:180250
|
Atp1a3tm1.1Tmklh/Atp1a3+
(B6JRj.129S1-Atp1a3tm1.1Tmklh)
|
increased susceptibility to pharmacologically induced seizures
|
J:254463
|
Atp1a3tm1Ling/Atp1a3+
(involves: 129 * Black Swiss)
|
enhanced behavioral response to addictive substance
|
J:117414
|
Atp1a3tm1Ute/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:262419
|
Atp6v1b2em1Pcamp/Atp6v1b2+
(C57BL/6N-Atp6v1b2em1Pcamp)
|
increased susceptibility to pharmacologically induced seizures
|
J:342781
|
Atp6v1b2em1Pcamp/Atp6v1b2em1Pcamp
(C57BL/6N-Atp6v1b2em1Pcamp)
|
increased susceptibility to pharmacologically induced seizures
|
J:342781
|
Avpr1btm1Dgen/Avpr1btm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Bace1tm1Pcw/Bace1tm1Pcw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
enhanced behavioral response to xenobiotic
|
J:133643
|
Baiap3tm1Smwk/Baiap3tm1Smwk
(B6N.129P2-Baiap3tm1Smwk)
|
abnormal behavioral response to xenobiotic
|
J:221234
|
increased susceptibility to pharmacologically induced seizures
|
J:221234
|
Bdnftm3Jae/Bdnftm3Jae Tg(Eno2tTA)5030Nes/0 Tg(tetO-cre)1Jaw/0
(involves: 129/Sv * C57BL/6 * ICR * SJL)
|
impaired behavioral response to xenobiotic
|
J:91563
|
Bhlhe40tm1.1Rhli/Bhlhe40tm1.1Rhli
(involves: 129S1/Sv * C57BL/6 * CD-1 * SJL)
|
increased susceptibility to pharmacologically induced seizures
|
J:131834
|
Bis1C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal seizure response to pharmacological agent
|
J:54925
|
Bis4A/J/?
(involves: A/J * C57BL/6J)
|
abnormal seizure response to pharmacological agent
|
J:54925
|
Bloc1s3rp/Bloc1s3rp
(involves: C57BL/10ScSn * C57BL/Tb)
|
enhanced behavioral response to anesthetic
|
J:29294
|
Braftm1Cpri/Braf+ Scn10atm2(cre)Jwo/Scn10a+
(involves: 129 * 129P2/OlaHsd)
|
enhanced behavioral response to xenobiotic
|
J:205122
|
Bsntm1Gund/Bsntm1Gund
(Not Specified)
|
increased susceptibility to pharmacologically induced seizures
|
J:82241
|
Cacna1atg/Cacna1atg
(B6.D2-Cacna1atg/J)
|
increased susceptibility to pharmacologically induced seizures
|
J:6154
|
Cacna1atm1Maag/Cacna1atm1Maag
(B6.129P2-Cacna1atm1Maag)
|
enhanced behavioral response to xenobiotic
|
J:144701
|
Cacna1atm3Maag/Cacna1a+
(B6.129P2-Cacna1atm3Maag)
|
enhanced behavioral response to xenobiotic
|
J:144701
|
Cacna1atm3Maag/Cacna1atm3Maag
(B6.129P2-Cacna1atm3Maag)
|
enhanced behavioral response to xenobiotic
|
J:144701
|
Cacna1btm1Hssh/Cacna1btm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
alcohol aversion
|
J:96593
|
decreased alcohol consumption
|
J:96593
|
enhanced behavioral response to alcohol
|
J:96593
|
impaired behavioral response to alcohol
|
J:96593
|
Cacna1btm1Ttan/Cacna1btm1Ttan
(involves: 129S4/SvJae * C57BL/6)
|
abnormal behavioral response to xenobiotic
|
J:107971
|
Cacna1gtm1.3Ksak/Cacna1gtm1.3Ksak
(involves: C57BL/6 * CBA)
|
impaired behavioral response to xenobiotic
|
J:151612
|
Cacna1gtm1Hssh/Cacna1gtm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
decreased susceptibility to pharmacologically induced seizures
|
J:70557
|
Cacna2d1tm1Cptl/Cacna2d1tm1Cptl
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired behavioral response to xenobiotic
|
J:117098
|
Cacna2d2tm1Svi/Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:92396
|
Cacnb4lh/Cacnb4lh
(involves: BALB/cGn * C3H/HeSnJ * C57BL/6JEi)
|
impaired behavioral response to xenobiotic
|
J:1484
|
Calcatm1Jpc/Calcatm1Jpc
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired behavioral response to xenobiotic
|
J:54422
|
Calcatm1Jpc/Calcatm1Jpc
(involves: 129P2/OlaHsd)
|
decreased behavioral withdrawal response
|
J:68693
|
enhanced behavioral response to nicotine
|
J:68693
|
Camk4tm1Gsc/Camk4tm1Gsc Tg(Drd1a-cre)1Gsc/0
(involves: 129 * FVB/N)
|
enhanced behavioral response to cocaine
|
J:142518
|
Cckbrtm1Tom/Cckbrtm1Tom
(involves: 129S4/SvJae * C57BL/6)
|
enhanced behavioral response to addictive substance
|
J:107970
|
enhanced behavioral response to morphine
|
J:107970
|
impaired behavioral response to cocaine
|
J:107970
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol)
|
alcohol aversion
|
J:102583
|
alcohol preference
|
J:102583
|
decreased alcohol consumption
|
J:102583
|
increased alcohol consumption
|
J:102583
|
Ccl2tm1Rol/Ccl2tm1Rol Ccr2tm1Mae/Ccr2tm1Mae
(B6.129-Ccr2tm1Mae Ccl2tm1Rol)
|
alcohol aversion
|
J:102583
|
alcohol preference
|
J:102583
|
decreased alcohol consumption
|
J:102583
|
Ccl3tm1Unc/Ccl3tm1Unc
(B6.129P2-Ccl3tm1Unc/J)
|
alcohol aversion
|
J:102583
|
decreased alcohol consumption
|
J:102583
|
Ccr2tm1Mae/Ccr2tm1Mae
(B6.129P2-Ccr2tm1Mae)
|
alcohol aversion
|
J:102583
|
decreased alcohol consumption
|
J:102583
|
increased alcohol consumption
|
J:102583
|
Ccr5tm1Kuz/Ccr5tm1Kuz
(B6.129P2-Ccr5tm1Kuz)
|
increased alcohol consumption
|
J:102583
|
Cd81tm1Geha/Cd81tm1Geha
(involves: 129S4/SvJae * C57BL/6)
|
impaired behavioral response to cocaine
|
J:69590
|
Cdk5r1tm1Lht/Cdk5r1tm1Lht
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:38857
|
Cdk5r1tm1Lht/Cdk5r1tm1Lht
(involves: 129S4/SvJae)
|
abnormal behavioral response to xenobiotic
|
J:204269
|
abnormal sensitization to xenobiotic
|
J:204269
|
Cdnftm1.1Uhb/Cdnftm1.1Uhb
(either: B6JRcc.129P2(Cg)-Cdnftm1.1Uhb or (involves: 129P2/OlaHsd * C57BL/6JRcc * ICR))
|
enhanced behavioral response to amphetamine
|
J:285339
|
Cdyltm1.1Yuw/Cdyltm1.1Yuw Emx1tm1(cre)Yql/Emx1+
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:251551
|
Chrm2tm1Jwe/Chrm2+
(involves: 129S4/SvJae * CF-1)
|
impaired behavioral response to xenobiotic
|
J:53061
|
Chrm2tm1Jwe/Chrm2tm1Jwe
(involves: 129S4/SvJae * CF-1)
|
impaired behavioral response to xenobiotic
|
J:60451
|
Chrm4tm1Minm/Chrm4tm1Minm
(involves: 129X1/SvJ * DBA/2J)
|
abnormal behavioral response to xenobiotic
|
J:99248
|
Chrm4tm2.1Jwe/Chrm4tm2.1Jwe Tg(Drd1a-cre)AGsc/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
enhanced behavioral response to addictive substance
|
J:157841
|
enhanced behavioral response to cocaine
|
J:157841
|
enhanced behavioral response to xenobiotic
|
J:157841
|
impaired behavioral response to xenobiotic
|
J:157841
|
Chrm5tm1Yeo/Chrm5tm1Yeo
(involves: 129X1/SvJ * CD-1)
|
impaired behavioral response to addictive substance
|
J:134260
|
Chrna4tm1.1Stit/Chrna4tm1.1Stit
(B6.129X1-Chrna4tm1.1Stit)
|
abnormal behavioral response to addictive substance
|
J:180872
|
Chrna4tm1.1Tmcg/Chrna4tm1.1Tmcg Slc6a3tm1(cre)Xz/Slc6a3+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6)
|
enhanced behavioral response to nicotine
|
J:174505
|
impaired behavioral response to nicotine
|
J:174505
|
Chrna4tm1.2Tmcg/Chrna4tm1.2Tmcg
(involves: 129S/SvEv * 129S1/Sv * C57BL/6)
|
impaired behavioral response to nicotine
|
J:174505
|
Chrna4tm1Dra/Chrna4tm1Dra
(involves: 129S4/SvJae * C57BL/6)
|
abnormal behavioral response to addictive substance
|
J:64208
|
increased susceptibility to pharmacologically induced seizures
|
J:97020
|
Chrna4tm1Lst/Chrna4+
(involves: C57BL/6)
|
enhanced behavioral response to nicotine
|
J:67863
|
impaired behavioral response to addictive substance
|
J:67863
|
Chrna4tm2.1Dra/Chrna4+
(involves: 129S1/Sv * CD-1)
|
abnormal behavioral response to addictive substance
|
J:125305
|
impaired behavioral response to nicotine
|
J:125305
|
Chrna4tm2.1Dra/Chrna4+
(involves: 129S1/Sv * C57BL/6 * CD-1)
|
abnormal behavioral response to addictive substance
|
J:125305
|
impaired behavioral response to nicotine
|
J:125305
|
Chrna4tm2.1Dra/Chrna4+
(B6.129S1-Chrna4tm2.1Dra)
|
abnormal behavioral response to addictive substance
|
J:125305
|
impaired behavioral response to nicotine
|
J:125305
|
Chrna4tm2Dra/Chrna4+
(involves: 129S1/Sv * CD-1)
|
abnormal behavioral response to addictive substance
|
J:125305
|
Chrna4tm2Lst/Chrna4tm2Lst
(involves: 129S1/Sv * C57BL/6)
|
enhanced behavioral response to nicotine
|
J:93873
|
Chrna5tm1Mdb/Chrna5tm1Mdb
(B6.129-Chrna5tm1Mdb)
|
decreased susceptibility to pharmacologically induced seizures
|
J:89266
|
Chrna5tm1Mdb/Chrna5tm1Mdb Chrnb4tm1Mdb/Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb Chrna5tm1Mdb)
|
decreased susceptibility to pharmacologically induced seizures
|
J:89266
|
Chrna7tm1Bay/Chrna7tm1Bay
(B6.Cg-Chrna7tm1Bay)
|
abnormal seizure response to pharmacological agent
|
J:74703
|
Chrnb2tm1.1Cont/Chrnb2+
(B6.129-Chrnb2tm1.1Cont)
|
abnormal behavioral response to nicotine
|
J:228269
|
Chrnb2tm1.1Cont/Chrnb2tm1.1Cont
(B6.129-Chrnb2tm1.1Cont)
|
abnormal behavioral response to nicotine
|
J:228269
|
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb)
|
decreased susceptibility to pharmacologically induced seizures
|
J:89266
|
Cittm1Fdc/Cittm1Fdc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased susceptibility to pharmacologically induced seizures
|
J:77297
|
Ckbtm1Bew/Ckbtm1Bew
(involves: 129P/Ola * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:89399
|
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal behavioral response to xenobiotic
|
J:80901
|
decreased susceptibility to pharmacologically induced seizures
|
J:80901
|
enhanced behavioral response to xenobiotic
|
J:80901
|
Cln3tm1Blda/Cln3tm1Blda
(B6.129-Cln3tm1Blda)
|
increased susceptibility to pharmacologically induced seizures
|
J:125194
|
Clockm1Jt/Clockm1Jt
(involves: C57BL/6)
|
enhanced behavioral response to cocaine
|
J:99868
|
Cm/+
(C3Sn.Cg-Cm/J)
|
abnormal behavioral response to addictive substance
|
J:156905
|
abnormal behavioral response to xenobiotic
|
J:32588
|
Cm/+ Drd3tm1Stl/Drd3tm1Stl
(involves: 101/H * 129S2/SvPas * C3H/HeH * C3H/HeSn * C57BL/6J)
|
abnormal behavioral response to addictive substance
|
J:156905
|
Cnr1tm1.1Kpm/Cnr1tm1.1Kpm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased behavioral withdrawal response
|
J:208116
|
Cnr1tm1.1Ltz/Cnr1+
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to pharmacologically induced seizures
|
J:89842
|
Cnr1tm1.1Ltz/Cnr1tm1.1Ltz
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to pharmacologically induced seizures
|
J:89842
|
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
(involves: 129P2/OlaHsd * C57BL/6NCrl)
|
increased susceptibility to pharmacologically induced seizures
|
J:122066
|
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz Neurod6tm1(cre)Kan/Neurod6+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)
|
increased susceptibility to pharmacologically induced seizures
|
J:122066
|
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to pharmacologically induced seizures
|
J:89842
|
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz Tg(Camk2a-cre)2Gsc/?
(involves: 129P2/OlaHsd * C57BL/6NCrl * FVB/N)
|
increased susceptibility to pharmacologically induced seizures
|
J:122066
|
Cnr1tm1Dgen/Cnr1tm1Dgen
(involves: 129S1/Sv * 129X1/SvJ)
|
impaired behavioral response to xenobiotic
|
J:144774
|
Cnr1tm1Map/Cnr1tm1Map
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
impaired behavioral response to addictive substance
|
J:52188
|
impaired behavioral response to morphine
|
J:52188
|
Cnr1tm1Zim/Cnr1tm1Zim
(involves: 129 * C57BL/6J)
|
impaired behavioral response to addictive substance
|
J:54995
|
Cnr1tm2Ltz/Cnr1tm2Ltz
(B6.Cg-Cnr1tm2Ltz)
|
increased susceptibility to pharmacologically induced seizures
|
J:199647
|
Cntn2tm1Fuka/Cntn2tm1Fuka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:67556
|
Cocia5C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal locomotor response to cocaine
|
J:88790
|
Cocia6A/J/?
(involves: A/J * C57BL/6J)
|
abnormal locomotor response to cocaine
|
J:88790
|
Cocia7C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal locomotor response to cocaine
|
J:88790
|
Cocia8C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal locomotor response to cocaine
|
J:88790
|
Cocia9C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal locomotor response to cocaine
|
J:88790
|
Cocia10C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal locomotor response to cocaine
|
J:88790
|
Cocia11C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal locomotor response to cocaine
|
J:88790
|
Cocia12C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal locomotor response to cocaine
|
J:88790
|
Cocia13A/J/?
(involves: A/J * C57BL/6J)
|
abnormal locomotor response to cocaine
|
J:88790
|
Cocia14C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal locomotor response to cocaine
|
J:88790
|
Coq8atm1.1Ics/Coq8atm1.1Ics
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N)
|
increased susceptibility to pharmacologically induced seizures
|
J:249129
|
Cosz1DBA/2J/Cosz1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:66464
|
Cosz2DBA/2J/Cosz2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:66464
|
Cosz3C57BL/6J/Cosz3C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:66464
|
Cosz3C57BL/6J/Cosz3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:66464
|
Creb1tm1Gsc/Creb1tm1Gsc
(involves: 129S2/SvPas)
|
abnormal behavioral response to addictive substance
|
J:34605
|
decreased behavioral withdrawal response
|
J:34605
|
Crhr1tm1Wrst/Crhr1+
(either: (involves: 129P2/OlaHsd * 129P/Ola) or (involves: 129P2/OlaHsd * CD-1))
|
decreased behavioral withdrawal response
|
J:76022
|
Crhr1tm1Wrst/Crhr1tm1Wrst
(either: (involves: 129P2/OlaHsd * 129P/Ola) or (involves: 129P2/OlaHsd * CD-1))
|
alcohol preference
|
J:76358
|
decreased behavioral withdrawal response
|
J:76022
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem Emx1tm1(cre)Yql/Emx1+
(B6.129-Emx1tm1(cre)Yql Ctnnb1tm2Kem)
|
increased susceptibility to pharmacologically induced seizures
|
J:92923
|
Cul4btm1Swl/Y Edil3Tg(Sox2-cre)1Amc/Edil3+
(B6.Cg-Edil3Tg(Sox2-cre)1Amc Cul4btm1Swl)
|
increased susceptibility to pharmacologically induced seizures
|
J:187403
|
Cx3cr1tm1.1(cre)Jung/Cx3cr1+ Sqorem1Chji/Sqorem1Chji
(B6(Cg)-Sqorem1Chji Cx3cr1tm1.1(cre)Jung)
|
impaired behavioral response to xenobiotic
|
J:314187
|
Cyfip2M1N/Cyfip2+
((C57BL/6N x C57BL/6J)F1)
|
impaired behavioral response to cocaine
|
J:203183
|
Cyfip2M1N/Cyfip2M1N
(C57BL/6N)
|
impaired behavioral response to cocaine
|
J:203183
|
Cyfip2M1N/Cyfip2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cyfip2M1N/Cyfip2tm1a(EUCOMM)Wtsi)
|
enhanced behavioral response to cocaine
|
J:203183
|
Cyp1a2tm1Dwn/Cyp1a2tm1Dwn
(either: (involves: 129P2/OlaHsd * Black Swiss) or (involves: 129P2/OlaHsd * CF-1))
|
enhanced behavioral response to xenobiotic
|
J:31730
|
Cyp2e1tm1Gonz/Cyp2e1tm1Gonz
(involves: 129S4/SvJae)
|
enhanced behavioral response to xenobiotic
|
J:143909
|
DaoG181R/DaoG181R
(DDY-Dao1G181R)
|
impaired behavioral response to xenobiotic
|
J:95950
|
Dbhtm2(Th)Rpa/Dbh+ Thtm1Rpa/Thtm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6J)
|
impaired behavioral response to addictive substance
|
J:58125
|
Dbptm1Schb/Dbptm1Schb Hlftm1Schb/Hlftm1Schb Teftm1Schb/Teftm1Schb
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
impaired behavioral response to xenobiotic
|
J:129710
|
Del(1Fmo4-Fmo2)1Eshe/+
(B6.129P2-Del(1Fmo4-Fmo2)1Eshe)
|
enhanced behavioral response to anesthetic
|
J:196270
|
Del(1Fmo4-Fmo2)1Eshe/Del(1Fmo4-Fmo2)1Eshe
(B6.129P2-Del(1Fmo4-Fmo2)1Eshe)
|
enhanced behavioral response to anesthetic
|
J:196270
|
Del(7Chrna7-Fan1)3Arte/+
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal seizure response to pharmacological agent
|
J:260165
|
decreased susceptibility to pharmacologically induced seizures
|
J:260165
|
Del(7Cyp2s1-Cyp2a5)1Ding/Del(7Cyp2s1-Cyp2a5)1Ding
(involves: BALB/cJ * C57BL/6)
|
enhanced behavioral response to anesthetic
|
J:190445
|
Del(7Mrgpra1-Mrgprb4)1And/Del(7Mrgpra1-Mrgprb4)1And
(involves: 129S1/Sv * C57BL/6)
|
impaired behavioral response to xenobiotic
|
J:157470
|
Depdc5tm1c(EUCOMM)Hmgu/Depdc5tm1c(EUCOMM)Hmgu Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6N * CBA)
|
increased susceptibility to pharmacologically induced seizures
|
J:260943
|
Depmq1C57BL/6J/Depmq1C57BL/6J
(involves: 129P3/J * C57BL/6J)
|
enhanced behavioral response to morphine
|
J:93071
|
DgkbTn(sb-lacZ,GFP)IR3.PV122Jtak/DgkbTn(sb-lacZ,GFP)IR3.PV122Jtak
(involves: C3H * C57BL/6 * C57BL/6N * DBA/2 * ICR)
|
impaired behavioral response to xenobiotic
|
J:204267
|
Disc1tm1(DISC1/DISC1FP1,DISC1FP1/DISC1,DISC1)Xzho/Disc1+
((129S2/SvPasCrl x C57BL)F1)
|
abnormal behavioral response to xenobiotic
|
J:214737
|
Disc1tm1(DISC1/DISC1FP1,DISC1FP1/DISC1,DISC1)Xzho/Disc1del
(129S2/SvPasCrl-Disc1del Disc1tm1(DISC1/DISC1FP1,DISC1FP1/DISC1,DISC1)Xzho)
|
abnormal behavioral response to xenobiotic
|
J:214737
|
Dlg4tm2.1Grnt/Dlg4tm2.1Grnt
(involves: 129P2/OlaHsd)
|
enhanced behavioral response to cocaine
|
J:89778
|
impaired behavioral response to cocaine
|
J:89778
|
Dlgap3tm1Gfng/Dlgap3tm1Gfng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
enhanced behavioral response to xenobiotic
|
J:125181
|
Dlk2tm1.1Geno/Dlk2tm1.1Geno
(involves: 129P2/OlaHsd * C57BL/6J)
|
impaired behavioral response to xenobiotic
|
J:272796
|
Drd1tm1Stl/Drd1tm1Stl
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired behavioral response to xenobiotic
|
J:21603
|
Drd1tm1Stl/Drd1tm1Stl
(involves: 129P2/OlaHsd)
|
impaired behavioral response to cocaine
|
J:112986
|
Drd1tm1Stl/Drd1tm1Stl
(involves: 129P2/OlaHsd * C57BL/6J)
|
impaired behavioral response to cocaine
|
J:127798
|
impaired behavioral response to xenobiotic
|
J:127798
|
Drd1tm2Rpa/Drd1tm2Rpa
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
impaired behavioral response to cocaine
|
J:121750
|
Drd2tm1.1Mrub/Drd2tm1.1Mrub Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(B6.Cg-Drd2tm1.1Mrub Slc6a3tm1.1(cre)Bkmn)
|
enhanced behavioral response to cocaine
|
J:176167
|
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:65767
|
Drd2tm1Low/Drd2+
(B6.129S2-Drd2tm1Low)
|
impaired behavioral response to alcohol
|
J:50787
|
Drd2tm1Low/Drd2tm1Low
(B6.129S2-Drd2tm1Low)
|
alcohol aversion
|
J:50787
|
decreased alcohol consumption
|
J:50787
|
impaired behavioral response to addictive substance
|
J:55027
|
impaired behavioral response to alcohol
|
J:50787
|
Drd2tm1Yyw/Drd2+
(B6.129S4-Drd2tm1Yyw)
|
abnormal behavioral response to xenobiotic
|
J:82829
|
Drd2tm1Yyw/Drd2tm1Yyw
(involves: 129S4/SvJae * C57BL/6)
|
impaired behavioral response to xenobiotic
|
J:65770
|
Drd2tm1Yyw/Drd2tm1Yyw
(B6.129S4-Drd2tm1Yyw)
|
abnormal behavioral response to xenobiotic
|
J:82829,
J:65770
|
Drd2tm2Ebo/Drd2tm2Ebo
(involves: 129S2/SvPas * C57BL/6)
|
enhanced behavioral response to xenobiotic
|
J:77277
|
impaired behavioral response to xenobiotic
|
J:77277
|
Drd2tm3.1Ebo/Drd2tm3.1Ebo En1tm2(cre)Wrst/En1+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
enhanced behavioral response to anesthetic
|
J:185643
|
enhanced behavioral response to cocaine
|
J:185643
|
enhanced behavioral response to xenobiotic
|
J:185643
|
Drd2tm3.1Ebo/Drd2tm3.1Ebo Tg(Drd1a-cre)AGsc/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
impaired behavioral response to anesthetic
|
J:185643
|
impaired behavioral response to cocaine
|
J:185643
|
Drd3tm1Dac/Drd3tm1Dac
(involves: 129S4/SvJae * C57BL/6)
|
impaired behavioral response to morphine
|
J:103701
|
Drd3tm1Dac/Drd3tm1Dac
(involves: 129S4/SvJae)
|
abnormal behavioral response to addictive substance
|
J:103704
|
decreased alcohol consumption
|
J:107932
|
enhanced behavioral response to alcohol
|
J:107932
|
increased behavioral withdrawal response
|
J:107932
|
Drd4tm1Dkg/Drd4tm1Dkg
(involves: 129P2/OlaHsd * C57BL/6J)
|
enhanced behavioral response to cocaine
|
J:43061
|
hyperactivity elicited by ethanol administration
|
J:43061
|
impaired behavioral response to addictive substance
|
J:43061
|
Drd5tm1Shay/Drd5tm1Shay
(B6.129P2-Drd5tm1Shay)
|
enhanced behavioral response to methamphetamine
|
J:209099
|
Dtnbp1sdy/Dtnbp1sdy
(DBA/2J-Dtnbp1sdy/J)
|
abnormal behavioral response to amphetamine
|
J:143912
|
Eac1C57BL/6ByJ/?
(involves: BALB/cJ * C57BL/6ByJ)
|
increased alcohol consumption
|
J:121226
|
Eac2BALB/cJ/Eac2BALB/cJ
(B6.C-(D6Mit275-D6Mit134))
|
decreased alcohol consumption
|
J:130072
|
Eac2C57BL/6ByJ/?
(involves: BALB/cJ * C57BL/6ByJ)
|
increased alcohol consumption
|
J:121226
|
Eac2C57BL/6ByJ/Eac2C57BL/6ByJ
(involves: BALB/cJ * C57BL/6ByJ)
|
increased alcohol consumption
|
J:130072
|
Eac3C57BL/6ByJ/?
(involves: BALB/cJ * C57BL/6ByJ)
|
increased alcohol consumption
|
J:121226
|
Eac4C57BL/6ByJ/?
(involves: BALB/cJ * C57BL/6ByJ)
|
increased alcohol consumption
|
J:121226
|
Eac5C57BL/6ByJ/?
(involves: BALB/cJ * C57BL/6ByJ)
|
increased alcohol consumption
|
J:121226
|
Eac6C57BL/6ByJ/?
(involves: BALB/cJ * C57BL/6ByJ)
|
increased alcohol consumption
|
J:121226
|
Ecpasem1Plch/Ecpasem1Plch
(C57BL/6-Ecpasem1Plch)
|
increased susceptibility to pharmacologically induced seizures
|
J:282974
|
Efhc1tm1Kzy/Efhc1+
(B6.129P2-Efhc1tm1Kzy)
|
increased susceptibility to pharmacologically induced seizures
|
J:145858
|
Efhc1tm1Kzy/Efhc1tm1Kzy
(B6.129P2-Efhc1tm1Kzy)
|
increased susceptibility to pharmacologically induced seizures
|
J:145858
|
Ehmt1tm1.1Tara/Ehmt1tm1.1Tara Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
impaired behavioral response to xenobiotic
|
J:155739
|
Ehmt2tm1.1Tara/Ehmt2tm1.1Tara Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
impaired behavioral response to xenobiotic
|
J:155739
|
Ehmt2tm1.1Tara/Ehmt2tm1.1Tara Tg(Drd1-cre)EY262Gsat/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
impaired behavioral response to xenobiotic
|
J:155739
|
Ehmt2tm1.1Tara/Ehmt2tm1.1Tara Tg(Drd2-cre)ER44Gsat/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
enhanced behavioral response to xenobiotic
|
J:155739
|
Eila1C57BL/6J/Eila1C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
hyperactivity elicited by ethanol administration
|
J:85747
|
Eila2C3H/HeJ/Eila2C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
hyperactivity elicited by ethanol administration
|
J:85747
|
Eila2C57BL/6J/Eila2C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
hyperactivity elicited by ethanol administration
|
J:85747
|
Eila3C3H/HeJ/Eila3C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
hyperactivity elicited by ethanol administration
|
J:85747
|
Eila3C3H/HeJ/Eila3C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
hyperactivity elicited by ethanol administration
|
J:85747
|
Elda3LS/?
(involves: LS * SS)
|
hyperactivity elicited by ethanol administration
|
J:114560
|
Elda4SS/?
(involves: LS * SS)
|
hyperactivity elicited by ethanol administration
|
J:114560
|
Elfn1tm1.1Jaru/Elfn1tm1.1Jaru
(involves: C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:226212
|
Elfn2tm1(KOMP)Vlcg/Elfn2tm1(KOMP)Vlcg
(C57BL/6NTac-Elfn2tm1(KOMP)Vlcg)
|
increased susceptibility to pharmacologically induced seizures
|
J:286127
|
Eml1heco/Eml1heco
(involves: NOR)
|
increased susceptibility to pharmacologically induced seizures
|
J:208031
|
Emx1tm1.1(cre)Ito/Emx1+ Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:139349
|
Eno2tm1(DTA)Hsak/Eno2+ Tg(Gpr151-cre)#Ito/0
(involves: C57BL/6)
|
impaired behavioral response to nicotine
|
J:214076
|
Eps8tm1Ppdf/Eps8tm1Ppdf
(B6.129P2-Eps8tm1Ppdf)
|
alcohol preference
|
J:116055
|
increased alcohol consumption
|
J:116055
|
Etan1C57BL/6J/Etan1MSM/Ms
(involves: C57BL/6J * MSM/Ms)
|
abnormal behavioral response to xenobiotic
|
J:94250
|
Etohc1C57BL/6J/Etohc1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal alcohol consumption
|
J:52468
|
Etohc1C57BL/6J/Etohc1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal alcohol consumption
|
J:52468
|
Etohc2C57BL/6J/Etohc2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal alcohol consumption
|
J:52468
|
Etohc3C57BL/6J/Etohc3C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal alcohol consumption
|
J:52468,
J:20482
|
Etohc3C57BL/6J/Etohc3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal alcohol consumption
|
J:52468
|
EtohrC57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
impaired behavioral response to alcohol
|
J:52042
|
EtohrDBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
hyperactivity elicited by ethanol administration
|
J:52042
|
Exq1A/J/?
(involves: A/J * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:54925
|
Exq1C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal seizure response to pharmacological agent
|
J:54925
|
Faahtm1Crv/Faahtm1Crv
(B6.129X1-Faahtm1Crv)
|
alcohol preference
|
J:109633
|
increased alcohol consumption
|
J:109633
|
Faim2tm1Dgen/Faim2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Fgf7tm1Efu/Fgf7tm1Efu
(B6.129-Fgf7tm1Efu)
|
increased susceptibility to pharmacologically induced seizures
|
J:161954
|
Fgf14tm1Dor/Fgf14tm1Dor
(129S6/SvEvTac-Fgf14tm1Dor)
|
increased susceptibility to pharmacologically induced seizures
|
J:77806
|
Fgf14tm1Dor/Fgf14tm1Dor
(B6.129S6-Fgf14tm1Dor)
|
increased susceptibility to pharmacologically induced seizures
|
J:77806
|
Fgf22tm1Dgen/Fgf22tm1Dgen
(B6.Cg-Fgf22tm1Dgen)
|
decreased susceptibility to pharmacologically induced seizures
|
J:161954
|
Fmc1em1Aitn/Fmc1+
(C57BL/6JJmsSlc-Fmc1em1Aitn)
|
impaired behavioral response to xenobiotic
|
J:257586
|
Fyntm1Yik/Fyntm1Yik
(involves: C57BL/6 * CBA)
|
enhanced behavioral response to alcohol
|
J:43707
|
Fzd9tm1Sjp/Fzd9tm1Sjp
(involves: C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:99893
|
Gabbr1tm1Bet/Gabbr1tm1Bet
(BALB/c-Gabbr1tm1Bet)
|
impaired behavioral response to xenobiotic
|
J:70558,
J:101866
|
Gabbr2tm1Bet/Gabbr2tm1Bet
(BALB/c-Gabbr2tm1Bet)
|
impaired behavioral response to xenobiotic
|
J:103989
|
Gabra1tm1.1Geh/Gabra1+
(B6.129(Cg)-Gabra1tm1.1Geh)
|
increased susceptibility to pharmacologically induced seizures
|
J:227437
|
Gabra1tm1.1Mjga/Gabra1+
(B6J.Cg-Gabra1tm1.1Mjga)
|
increased susceptibility to pharmacologically induced seizures
|
J:227437
|
Gabra1tm1.1Uru/Gabra1tm1.1Uru
(either: 129X1.129P2-Gabra1tm1.1Uru or B6.129P2-Gabra1tm1.1Uru)
|
impaired behavioral response to xenobiotic
|
J:75895
|
increased susceptibility to pharmacologically induced seizures
|
J:75895
|
Gabra1tm1Rmck/Gabra1tm1Rmck
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6)
|
abnormal behavioral response to xenobiotic
|
J:62214
|
Gabra2tm1.1Dias/Gabra2tm1.1Dias
(involves: 129S7/SvEvBrd * C57BL/6J)
|
impaired behavioral response to xenobiotic
|
J:108919
|
Gabra2tm1.1Geh/Gabra2tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
enhanced behavioral response to anesthetic
|
J:171967
|
Gabra2tm1.1Uru/Gabra2tm1.1Uru
(129-Gabra2tm1.1Uru)
|
impaired behavioral response to xenobiotic
|
J:65100
|
Gabra4tm1.1Geh/Gabra4tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
impaired behavioral response to xenobiotic
|
J:115154
|
Gabra5tm1.1Uru/Gabra5tm1.1Uru
(129X1/SvJ-Gabra5tm1.1Uru)
|
abnormal behavioral response to xenobiotic
|
J:77343
|
Gabrb1m1Qnma/Gabrb1+
(involves: BALB/cAnN * C3H/HeH)
|
alcohol preference
|
J:223500
|
enhanced behavioral response to alcohol
|
J:223500
|
Gabrb1m2Qnma/Gabrb1+
(involves: BALB/cAnN * C3H/HeH)
|
alcohol preference
|
J:223500
|
Gabrb2tm1.1Kwa/Gabrb2tm1.1Kwa
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal behavioral response to xenobiotic
|
J:85526
|
Gabrb3tm1Uru/Gabrb3tm1Uru
(involves: 129X1/SvJ * C57BL/6J)
|
impaired behavioral response to xenobiotic
|
J:81497
|
Gabrb3tm2.1Geh/Gabrb3tm2.1Geh Tg(Camk2a-cre)T29-1Stl/?
(involves: 129 * BALB/c * C57BL/6 * SJL)
|
impaired behavioral response to xenobiotic
|
J:127877
|
Gabrb3tm2.1Geh/Gabrb3tm2.1Geh Tg(Syn1-cre)671Jxm/?
(involves: 129 * C57BL/6 * CBA * SJL)
|
impaired behavioral response to xenobiotic
|
J:127877
|
Gabrb3tm2.1Uru/Gabrb3tm2.1Uru
(B6J.129S6(Cg)-Gabrb3tm2.1Uru)
|
increased susceptibility to pharmacologically induced seizures
|
J:228332
|
Gabrdtm1.1Jmag/Gabrd+ Gad2tm2(cre)Zjh/Gad2+
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased susceptibility to pharmacologically induced seizures
|
J:203336
|
Gabrdtm1Geh/Gabrdtm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
impaired behavioral response to anesthetic
|
J:64288
|
Gabretm1Cya/Gabretm1Cya
(Not Specified)
|
impaired behavioral response to anesthetic
|
J:278734
|
Gabrg2tm1.2Rmac/Gabrg2+
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to pharmacologically induced seizures
|
J:306976
|
Gabrg2tm1Dc/Gabrg2tm1Dc
(involves: 129P2/OlaHsd * C57BL/6J)
|
impaired behavioral response to xenobiotic
|
J:97175
|
Gabrg2tm1Geh/Gabrg2tm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
enhanced behavioral response to xenobiotic
|
J:102772
|
Gabrg2tm1Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:127120
|
Gabrg2tm1Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
|
increased susceptibility to pharmacologically induced seizures
|
J:194736
|
Gabrg2tm1Wul/Gabrg2tm1Wul Tg(Pcp2-cre)2Mpin/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired behavioral response to xenobiotic
|
J:124171
|
Gabrg2tm1Wul/Gabrg2tm1Wul Tg(Pcp2-cre)2Mpin/? Tg(Pcp2-EGFP/Gabrg2)1Wul/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
impaired behavioral response to xenobiotic
|
J:124171
|
Gabrg2tm2Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to pharmacologically induced seizures
|
J:194196
|
Gabrg2tm2Spet/Gabrg2+ Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-cre)LC1Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:194736
|
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn)
|
increased susceptibility to pharmacologically induced seizures
|
J:77625
|
Gdi1tm1Ytk/Gdi1tm1Ytk
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * C57BL/6 * DBA/2))
|
increased susceptibility to pharmacologically induced seizures
|
J:65258
|
Gfaptm2Mes/Gfap+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N)
|
increased susceptibility to pharmacologically induced seizures
|
J:114689
|
Glra1tm1.1Geh/Glra1tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to pharmacologically induced seizures
|
J:177105
|
Glra1tm2.1Geh/Glra1tm2.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to pharmacologically induced seizures
|
J:177106
|
Glra3tm1Dgen/Glra3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Glstm2.1Sray/Gls+ Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
impaired behavioral response to amphetamine
|
J:230564
|
Gm41261em1Geh/Gm41261em1Geh
(C57BL/6J-Gm41261em1Geh)
|
abnormal behavioral response to alcohol
|
J:345829
|
abnormal behavioral response to xenobiotic
|
J:345829
|
decreased alcohol consumption
|
J:345829
|
impaired behavioral response to alcohol
|
J:345829
|
Gnastm1Gwa/Gnas+
(either: (involves: 129S4/SvJae * 129/Sv) or (involves: 129S4/SvJae * C57BL/6J) or (involves: 129S4/SvJae * CD-1))
|
decreased alcohol consumption
|
J:70175
|
Gnaztm1Lfb/Gnaztm1Lfb
(involves: 129/Sv * C57BL/6 * C57BL/6J * SJL)
|
enhanced behavioral response to cocaine
|
J:77282
|
impaired behavioral response to addictive substance
|
J:77282
|
Gpr26tm1Zgwg/Gpr26tm1Zgwg
(involves: 129 * C57BL/6)
|
alcohol preference
|
J:182811
|
Gpr52tm1Kohi/Gpr52tm1Kohi
(involves: 129S/SvEv)
|
enhanced behavioral response to xenobiotic
|
J:214470
|
Gpr88tm1.1(cre/GFP)Rpa/Gpr88tm1.1(cre/GFP)Rpa
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal behavioral response to xenobiotic
|
J:193543
|
enhanced behavioral response to amphetamine
|
J:193543
|
Gpr139tm1.1(KOMP)Vlcg/Gpr139tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased behavioral withdrawal response
|
J:280704
|
Gprasp1tm1.1Jlw/Gprasp1tm1.1Jlw
(involves: C57BL/6)
|
impaired behavioral response to cocaine
|
J:161807
|
Gprasp1tm1Ics/Gprasp1tm1Ics
(involves: 129S2/SvPas * C57BL/6J)
|
impaired behavioral response to cocaine
|
J:153526
|
Gprin3em1Sns/Gprin3em1Sns
(C57BL/6-Gprin3em1Sns)
|
impaired behavioral response to cocaine
|
J:279507
|
Gria1tm1Rsp/Gria1tm1Rsp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal behavioral response to xenobiotic
|
J:75498
|
decreased behavioral withdrawal response
|
J:75498
|
Gria3tm1.1Rsp/Y
(B6.129-Gria3tm1.1Rsp)
|
decreased alcohol consumption
|
J:104146
|
Gria3tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:101679
|
Gria4tm1Dgen/Gria4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal seizure response to pharmacological agent
|
J:101679
|
Grik2tm1Bvis/Grik2tm1Bvis
(129S/Sv-Grik2tm1Bvis)
|
increased susceptibility to pharmacologically induced seizures
|
J:107698
|
Grik2tm1Sfh/Grik2tm1Sfh
(involves: 129S1/Sv * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:46932
|
Grik4tm1(cre)Mim/Grik4+ Grin1tm1Mim/Grin1tm1Mim
(involves: C57BL/6N)
|
increased susceptibility to pharmacologically induced seizures
|
J:144994
|
Grik5tm1Dgen/Grik5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Grin1Rgsc174/Grin1+
(C57BL/6J-Grin1Rgsc174)
|
abnormal behavioral response to xenobiotic
|
J:160947
|
Grin1tm1Blt/Grin1tm1Blt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:62289
|
Grin1tm1Jjwd/Grin1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal behavioral response to alcohol
|
J:209690
|
decreased alcohol consumption
|
J:209690
|
increased alcohol consumption
|
J:209690
|
Grin1tm1Rpa/Grin1tm1.1Rpa Slc6a3tm1(cre)Xz/Slc6a3+
(involves: 129S1/Sv)
|
abnormal behavioral response to addictive substance
|
J:145468
|
Grin1tm1Rsp/Grin1tm1Rsp Tg(Slc6a3-icre)9075Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
impaired behavioral response to cocaine
|
J:139693
|
Grin1tm1Rsp/Grin1tm1Rsp Tg(Slc6a3-icre)9075Gsc/0
(involves: 129S1/Sv * 129X1/SvJ)
|
impaired behavioral response to cocaine
|
J:139693
|
Grk6tm1.1Mca/Grk6+
(involves: 129S4/SvJae * C57BL/6J)
|
enhanced behavioral response to addictive substance
|
J:83191
|
enhanced behavioral response to cocaine
|
J:83191
|
Grk6tm1.1Mca/Grk6tm1.1Mca
(involves: 129S4/SvJae * C57BL/6J)
|
enhanced behavioral response to addictive substance
|
J:83191
|
enhanced behavioral response to cocaine
|
J:83191
|
Grm2tm1Nak/Grm2tm1Nak
(B6.129S-Grm2tm1Nak)
|
cocaine preference
|
J:97172
|
Grm5tm1.1Kksz/Grm5tm1.1Kksz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased alcohol consumption
|
J:151084
|
Grm5tm1Dgen/Grm5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased susceptibility to pharmacologically induced seizures
|
J:82809
|
increased susceptibility to pharmacologically induced seizures
|
J:82809
|
Grm5tm1Fcq/Grm5tm1Fcq
(Not Specified)
|
abnormal cocaine consumption
|
J:97288
|
impaired behavioral response to cocaine
|
J:97288
|
Grm7tm1Betz/Grm7tm1Betz
(B6.129P2-Grm7tm1Betz)
|
increased susceptibility to pharmacologically induced seizures
|
J:138831
|
Grm7tm1Dgen/Grm7tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Gsg1ltm1.2Tern/Gsg1ltm1.2Tern
(C57BL/6J-Gsg1ltm1.2Tern)
|
increased susceptibility to pharmacologically induced seizures
|
J:301313
|
Gsk3atm1Dral/Gsk3atm1Dral Gsk3btm1Dral/Gsk3btm1Dral
(involves: 129P2/OlaHsd)
|
abnormal behavioral response to xenobiotic
|
J:200517
|
Gstm1tm1Gcw/Gstm1tm1Gcw
(involves: 129S/SvEv * C57BL/6)
|
abnormal behavioral response to xenobiotic
|
J:159701
|
Gt(ROSA)26Sortm1(Crh)Jde/Gt(ROSA)26Sortm1(Crh)Jde Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal seizure response to pharmacological agent
|
J:140968
|
Gt(ROSA)26Sortm2(Ubc-GPR52)Kohi/Gt(ROSA)26Sor+ Tg(Gpr52-cre)116FKohi/0
(involves: 129S/SvEv * C57BL/6J)
|
impaired behavioral response to methamphetamine
|
J:214470
|
Hbegftm1Hhar/Hbegftm1Hhar Tg(Six3-cre)69Frty/0
(involves: C57BL/6 * CBA * DBA/2)
|
abnormal behavioral response to xenobiotic
|
J:154094
|
Hcn2ap/Hcn2+
(DW/Pas-Hcn2ap)
|
increased susceptibility to pharmacologically induced seizures
|
J:146530
|
Hcrtr1tm1Dgen/Hcrtr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Hcrtr1tm1Dgen/Hcrtr1tm1Dgen
(B6.129P2-Hcrtr1tm1Dgen/J)
|
abnormal cocaine consumption
|
J:208627,
J:216923
|
low preference for an addictive substance
|
J:208627,
J:216923
|
Hdctm1Nagy/Hdc+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal behavioral response to amphetamine
|
J:220412
|
Hdctm1Nagy/Hdctm1Nagy
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal behavioral response to amphetamine
|
J:220412
|
Hipk2tm1Ejh/Hipk2tm1Ejh
(involves: 129X1/SvJ * C57BL/6)
|
impaired behavioral response to addictive substance
|
J:117465
|
hipr/hipr
(involves: C57BL/6J)
|
enhanced behavioral response to cocaine
|
J:196485
|
hyperactivity elicited by ethanol administration
|
J:196485
|
Hltftm1.1Arte/Hltftm1.1Arte
(Not Specified)
|
impaired behavioral response to xenobiotic
|
J:193813
|
Hnrnph1em1Lagbu/Hnrnph1+
(C57BL/6J-Hnrnph1em1Lagbu)
|
impaired behavioral response to methamphetamine
|
J:232145
|
Homer1tm1Mhd/Homer1tm1Mhd
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)
|
enhanced behavioral response to cocaine
|
J:96554
|
Homer2tm1Mhd/Homer2tm1Mhd
(B6.129-Homer2tm1Mhd)
|
abnormal cocaine consumption
|
J:96554
|
enhanced behavioral response to cocaine
|
J:96554
|
Hpic3LP/J/?
(involves: BALB/cJ * LP/J)
|
impaired behavioral response to xenobiotic
|
J:58047
|
Hpic4LP/J/?
(involves: BALB/cJ * LP/J)
|
impaired behavioral response to xenobiotic
|
J:58047
|
Hprt1tm1(CAG-Glra3*)Jcme/Y Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
increased susceptibility to pharmacologically induced seizures
|
J:207981
|
Htr1atm1Toth/Htr1atm1Toth
(involves: 129P2/OlaHsd * Black Swiss)
|
increased susceptibility to pharmacologically induced seizures
|
J:66581
|
Htr2ctm1Jke/Y
(B6.129-Htr2ctm1Jke)
|
impaired behavioral response to xenobiotic
|
J:147514
|
Htr2ctm1Jul/Y
(either: (involves: 129S2/SvPas * C57BL/6J * DBA/2) or (involves: 129S4/SvJae * C57BL/6J * DBA/2))
|
impaired behavioral response to xenobiotic
|
J:24339
|
increased susceptibility to pharmacologically induced seizures
|
J:24339
|
Htr2ctm1Knk/Y
(B6.Cg-Htr2ctm1Knk)
|
enhanced behavioral response to xenobiotic
|
J:142503
|
Htr4tm1Comp/Htr4tm1Comp
(129/Sv-Htr4tm1Comp)
|
increased susceptibility to pharmacologically induced seizures
|
J:87451
|
Htr6tm1Tct/Htr6tm1Tct
(involves: 129X1/SvJ * C57BL/6J)
|
hyperactivity elicited by ethanol administration
|
J:148381
|
impaired behavioral response to alcohol
|
J:148381
|
Htr7tm1Wtkn/Htr7tm1Wtkn
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased susceptibility to pharmacologically induced seizures
|
J:124549
|
Igsf9tm1Kln/Igsf9tm1Kln
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:209586
|
Il6tm1Poli/Il6tm1Poli
(involves: 129S/SvEv * MF1)
|
enhanced behavioral response to morphine
|
J:89398
|
Impa1tm1Lex/Impa1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:157887
|
Iqsec2em1Frk/Y
(involves: C3HeB/FeJ * C57BL/6NJ)
|
decreased susceptibility to pharmacologically induced seizures
|
J:284762
|
Juntm2.1Wag/Juntm2.1Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased susceptibility to pharmacologically induced seizures
|
J:53481
|
Kcna1tm1Tem/Kcna1+
(involves: 129S7/SvEvBrd * various)
|
increased susceptibility to pharmacologically induced seizures
|
J:47349
|
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * various)
|
increased susceptibility to pharmacologically induced seizures
|
J:47349
|
Kcna2tm1Tem/Kcna2+
(C3Fe.129S7-Kcna2tm1Tem)
|
increased susceptibility to pharmacologically induced seizures
|
J:131735
|
Kcna2tm1Tem/Kcna2tm1Tem
(C3Fe.129S7-Kcna2tm1Tem)
|
increased susceptibility to pharmacologically induced seizures
|
J:131735
|
Kcnc1tm1Joho/Kcnc1tm1Joho Kcnc3tm1Echa/Kcnc3tm1Echa
(involves: 129/Sv * C57BL/6)
|
enhanced behavioral response to alcohol
|
J:71179
|
Kcnc2tm1Rudy/Kcnc2tm1Rudy
(B6.129S1-Kcnc2tm1Rudy)
|
increased susceptibility to pharmacologically induced seizures
|
J:66730
|
Kcnh3tm1.2Tije/Kcnh3tm1.2Tije
(involves: C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:165296
|
Kcnip1tm1Zhzh/Kcnip1tm1Zhzh
(involves: C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:227383
|
Kcnj6tm1Stf/Kcnj6tm1Stf
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to pharmacologically induced seizures
|
J:38206
|
Kcnk2tm1Lzd/Kcnk2tm1Lzd
(involves: 129 * C57BL/6J)
|
impaired behavioral response to xenobiotic
|
J:91531
|
increased susceptibility to pharmacologically induced seizures
|
J:91531
|
Kcnq2Nmf134/Kcnq2+
(C57BL/6J-Kcnq2Nmf134)
|
increased susceptibility to pharmacologically induced seizures
|
J:136510
|
Kcnq2tm1Dgen/Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Kcnq2tm1Hsa/Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:62797
|
Kcnt1em1Lekk/Kcnt1+
(C57BL/6J-Kcnt1em1Lekk)
|
increased susceptibility to pharmacologically induced seizures
|
J:287751
|
Kdm1atm1Ebg/Kdm1atm1Ebg
(B6.129-Kdm1atm1Ebg)
|
decreased susceptibility to pharmacologically induced seizures
|
J:235553
|
Kif4em1Noh/Y
(C57BL/6J-Kif4em1Noh)
|
increased susceptibility to pharmacologically induced seizures
|
J:336792
|
KitW-sh/KitW-sh
(involves: 101/H * C3H/HeH)
|
impaired behavioral response to xenobiotic
|
J:157470
|
Klk8tm1Lth/Klk8tm1Lth
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:71533
|
L2hgdhGt(DC0625)Wtsi/L2hgdhGt(DC0625)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:228407
|
Lamp2tm1Amcu/Y Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
enhanced behavioral response to xenobiotic
|
J:215605
|
Lamp5em1Lmit/Lamp5+
(C57BL/6-Lamp5em1Lmit)
|
increased susceptibility to pharmacologically induced seizures
|
J:345459
|
Lamp5em1Lmit/Lamp5em1Lmit
(C57BL/6-Lamp5em1Lmit)
|
increased susceptibility to pharmacologically induced seizures
|
J:345459
|
Letm1Gt(CC0204)Wtsi/Letm1+
(129S.129P2-Letm1Gt(CC0204)Wtsi)
|
increased susceptibility to pharmacologically induced seizures
|
J:222017
|
Letm1Gt(DD0926)Wtsi/Letm1+
(129S.129P2-Letm1Gt(DD0926)Wtsi)
|
increased susceptibility to pharmacologically induced seizures
|
J:222017
|
Lgi1tm1Mafu/Lgi1+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:157578
|
Lhx6tm1Vpa/Lhx6tm2Vpa
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:198547
|
Lmo4Gt(RRO142)Byg/Lmo4+
(involves: 129P2/OlaHsd * C57BL/6J)
|
enhanced behavioral response to cocaine
|
J:178212
|
Lmtk3tm1Tya/Lmtk3tm1Tya
(B6JJcl.Cg-Lmtk3tm1Tya)
|
enhanced behavioral response to xenobiotic
|
J:210612
|
Lorp1LS/Lorp1SS
(involves: LS * SS)
|
enhanced behavioral response to xenobiotic
|
J:46300
|
Lrrc4btm1Lex/Lrrc4btm1Lex
(involves: 129S/SvEv * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:276446
|
Lrrk2tm1.1Shn/Lrrk2tm1.1Shn
(involves: 129 * C57BL/6)
|
impaired behavioral response to addictive substance
|
J:151944
|
impaired behavioral response to xenobiotic
|
J:151944
|
Lystbg/Lystbg
(B6.C3Rl-Lystbg)
|
enhanced behavioral response to xenobiotic
|
J:29294
|
Map6tm1Job/Map6tm1Job
(involves: 129S2/SvPas * C57BL/6)
|
abnormal behavioral response to amphetamine
|
J:225083
|
Mapk10tm1Flv/Mapk10tm1Flv
(involves: 129S1/Sv)
|
decreased susceptibility to pharmacologically induced seizures
|
J:43658
|
Mapttm1Hnd/Mapt+
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:121330
|
Mapttm1Hnd/Mapt+ Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased susceptibility to pharmacologically induced seizures
|
J:121330
|
Mapttm1Hnd/Mapttm1Hnd
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:121330
|
Mapttm1Hnd/Mapttm1Hnd Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased susceptibility to pharmacologically induced seizures
|
J:121330
|
Marq1DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to addictive substance
|
J:100797
|
Marq2DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to addictive substance
|
J:100797
|
Marq3DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
impaired behavioral response to addictive substance
|
J:100797
|
Marq4DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to addictive substance
|
J:100797
|
Marq5DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to addictive substance
|
J:100797
|
Mbnl2tm1.1Sws/Mbnl2+
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:218010
|
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:218010
|
Mbpshi/Mbpshi Tg(Thy1-YFP)HJrs/0
(involves: C3HeB/Fe * C57BL/6 * CBA * SWV)
|
increased susceptibility to pharmacologically induced seizures
|
J:158545
|
Mc2rtm1Dgen/Mc2rtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:82809
|
Mchr1tm1.1Blak/Mchr1tm1.1Blak
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * FVB/N)
|
impaired behavioral response to xenobiotic
|
J:133199
|
Mecp2tm3Meg/Y
(B6.129-Mecp2tm3Meg)
|
increased susceptibility to pharmacologically induced seizures
|
J:204723
|
MgllGt(OST113734)Lex/MgllGt(OST113734)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
impaired behavioral response to xenobiotic
|
J:165274
|
Miattm1Shna/Miattm1Shna
(B6.Cg-Miattm1Shna/Shna)
|
enhanced behavioral response to methamphetamine
|
J:250154
|
Mir425em1Nju/Mir425+
(involves: C57BL/6)
|
impaired behavioral response to xenobiotic
|
J:280159
|
Mop1C57BL/6J/Mop1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
preference for addictive substance
|
J:17972
|
Mop1C57BL/6J/Mop1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
preference for addictive substance
|
J:17972
|
Mop2C57BL/6J/Mop2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
preference for addictive substance
|
J:17972
|
Mop2C57BL/6J/Mop2C57BL/6J
(D2.B6-Mop2C57BL/6J)
|
preference for addictive substance
|
J:99472
|
Mop2C57BL/6J/Mop2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
preference for addictive substance
|
J:17972
|
Mop2DBA/2J/Mop2DBA/2J
(B6.D2-Mop2DBA/2J)
|
preference for addictive substance
|
J:99472
|
Mop3C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
aversion to addictive substance
|
J:17972
|
MpdzGt(XG734)Byg/Mpdz+
(involves: 129P2/OlaHsd * C57BL/6)
|
alcohol aversion
|
J:226456
|
decreased alcohol consumption
|
J:226456
|
increased behavioral withdrawal response
|
J:226456
|
Mt1tm1Bri/Mt1tm1Bri Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J)
|
increased susceptibility to pharmacologically induced seizures
|
J:89429
|
Mt3tm1Rpa/Mt3tm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:38222
|
Mto1Gt(G019A03)Wrst/Mto1Gt(G019A03)Wrst
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal behavioral response to anesthetic
|
J:223246
|
n-TRtct5m1J/n-TRtct5m1J
(C57BL/6J)
|
abnormal seizure response to pharmacological agent
|
J:297745
|
n-TRtct5tm1.1Slac/n-TRtct5tm1.1Slac
(C57BL/6J-n-TRtct5tm1.1Slac)
|
abnormal seizure response to pharmacological agent
|
J:297745
|
n-TRtct5tm2.1Slac/n-TRtct5tm2.1Slac
(C57BL/6NJ-n-TRtct5tm2.1Slac)
|
abnormal seizure response to pharmacological agent
|
J:297745
|
Nacc1tm1Jabl/Nacc1tm1Jabl
(involves: 129S6/SvEvTac)
|
enhanced behavioral response to cocaine
|
J:128447
|
Ncdntm1.1Mfla/Ncdntm1.1Mfla Tg(Camk2a-cre)2Gsc/0
(involves: C57BL/6 * FVB/N)
|
enhanced behavioral response to xenobiotic
|
J:155805
|
Neurod2tm1Tap/Neurod2tm1Tap
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:69606
|
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
increased susceptibility to pharmacologically induced seizures
|
J:218959
|
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal seizure response to pharmacological agent
|
J:210491
|
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg Gys1tm1c(EUCOMM)Wtsi/Gys1+ Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac)
|
abnormal seizure response to pharmacological agent
|
J:210491
|
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg Gys1tm1c(EUCOMM)Wtsi/Gys1tm1c(EUCOMM)Wtsi Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac)
|
abnormal seizure response to pharmacological agent
|
J:210491
|
Nicoq1C57BL/6J/Nicoq1C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
preference for addictive substance
|
J:137282
|
Nicoq2C57BL/6J/Nicoq2C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
preference for addictive substance
|
J:137282
|
Nicoq3C3H/HeJ/Nicoq3C3H/HeJ
(involves: C3H/HeJ * C57BL/6J)
|
preference for addictive substance
|
J:137282
|
Nicoq4C57BL/6J/Nicoq4C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
preference for addictive substance
|
J:137282
|
Nilac1A/J/Nilac1A/J
(involves: A/J * C57BL/6J)
|
impaired behavioral response to nicotine
|
J:143889
|
Nilac1C57BL/6J/?
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:109827
|
Nilac2C57BL/6J/?
(involves: A/J * C57BL/6J)
|
impaired behavioral response to nicotine
|
J:109827
|
Nilac3A/J/?
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:109827
|
Nilac3A/J/Nilac3A/J
(C57BL/6J-Chr 2A/J/NaJ)
|
enhanced behavioral response to nicotine
|
J:143889
|
Nilac4A/J/?
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:109827
|
Nilac5A/J/?
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:109827
|
Nilac6A/J/?
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:109827
|
Nilac7C57BL/6J/?
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:109827
|
Nilac8A/J/?
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:109827
|
Nilac9A/J/Nilac9A/J
(C57BL/6J-Chr 14A/J/NaJ)
|
enhanced behavioral response to nicotine
|
J:143889
|
Nilac9C57BL/6J/?
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:109827
|
Nilac10A/J/?
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:109827
|
Nilac10A/J/Nilac10A/J
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:143889
|
Nilac10A/J/Nilac10A/J
(C57BL/6J-Chr 16A/J/NaJ)
|
enhanced behavioral response to nicotine
|
J:143889
|
Nilac10A/J/Nilac10C57BL/6J
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:143889
|
Nilac11A/J/Nilac11A/J
(C57BL/6J-Chr 17A/J/NaJ)
|
enhanced behavioral response to nicotine
|
J:143889
|
Nilac11C57BL/6J/?
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:109827
|
Nilac12A/J/?
(involves: A/J * C57BL/6J)
|
enhanced behavioral response to nicotine
|
J:109827
|
NipblGt(RRS564)Byg/Nipbl+
(involves: 129P2/OlaHsd * CD-1)
|
abnormal behavioral response to anesthetic
|
J:154117
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal behavioral response to addictive substance
|
J:79215
|
enhanced behavioral response to addictive substance
|
J:79215
|
increased alcohol consumption
|
J:79215
|
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau)
|
increased susceptibility to pharmacologically induced seizures
|
J:107300
|
Npas3tm1Ewb/Npas3tm1Ewb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal behavioral response to xenobiotic
|
J:101561
|
Npy1rtm1Tped/Npy1rtm1Tped
(B6.129P2-Npy1rtm1Tped)
|
impaired behavioral response to alcohol
|
J:109207
|
increased alcohol consumption
|
J:109207
|
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:124729
|
Npy2rtm1Pern/Npy2rtm1Pern
(involves: 129/Sv * BALB/cJ)
|
alcohol aversion
|
J:102430
|
Npytm1Rpa/Npytm1Rpa
(involves: 129S7/SvEvBrd)
|
increased susceptibility to pharmacologically induced seizures
|
J:33261
|
Npytm2Rpa/Npytm2Rpa
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:104699
|
Nr1d2tm1.1Pbrc/Nr1d2tm1.1Pbrc
(involves: C57BL/6J)
|
impaired behavioral response to xenobiotic
|
J:225389
|
Nr1i2tm1Sakl/Nr1i2tm1Sakl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired behavioral response to xenobiotic
|
J:103505
|
Nr3c1tm2Gsc/Nr3c1tm2Gsc Tg(Drd1a-cre)AGsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal behavioral response to addictive substance
|
J:150544
|
Nr4a2tm1Tpe/Nr4a2+
(B6.129P2-Nr4a2tm1Tpe)
|
enhanced behavioral response to addictive substance
|
J:147544
|
enhanced behavioral response to xenobiotic
|
J:147544
|
Nr4a3tm1Omc/Nr4a3tm1Omc
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:93320
|
Nrp2tm1.2Mom/Nrp2+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)
|
increased susceptibility to pharmacologically induced seizures
|
J:166116
|
Nrp2tm1.2Mom/Nrp2tm1.2Mom
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)
|
increased susceptibility to pharmacologically induced seizures
|
J:166116
|
Ntmtm1Lex/Ntm+
(involves: 129S5/SvEvBrd * C57BL/6)
|
impaired behavioral response to amphetamine
|
J:249103
|
Ntmtm1Lex/Ntmtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
impaired behavioral response to amphetamine
|
J:249103
|
Ntrk2tm2Kln/Ntrk2tm2Kln Tg(Penk-cre,-lacZ)1Mini/0
(involves: 129S2/SvPas)
|
enhanced behavioral response to cocaine
|
J:204429
|
Oprd1tm1Dgen/Oprd1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Oprd1tm1Jep/Oprd1tm1Jep
(involves: 129S/SvEv * C57BL/6J)
|
abnormal behavioral response to addictive substance
|
J:109209
|
Oprd1tm1Jep/Oprd1tm1Jep Oprm1tm1Jep/Oprm1tm1Jep Oprm1tm1Jep/Oprm1tm1Jep
(involves: 129S/SvEv * 129S2/SvPas)
|
impaired behavioral response to anesthetic
|
J:124042
|
impaired behavioral response to morphine
|
J:124042
|
Oprk1tm1.1Waca/Oprk1tm1.1Waca Tg(Slc6a3-icre)9075Gsc/0
(B6J.Cg-Oprk1tm1.1Waca Tg(Slc6a3-icre)9075Gsc)
|
enhanced behavioral response to cocaine
|
J:211750
|
Oprk1tm1Jep/Oprk1tm1Jep
(Not Specified)
|
impaired behavioral response to anesthetic
|
J:65217
|
Oprk1tm1Kff/Oprk1tm1Kff
(involves: 129S2/SvPas * C57BL/6)
|
impaired behavioral response to morphine
|
J:46089
|
Oprl1tm1Hta/Oprl1tm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
impaired behavioral response to morphine
|
J:70568
|
Oprm1IAP/Oprm1IAP
(CXB7/ByJ)
|
impaired behavioral response to morphine
|
J:283389
|
Oprm1tm1.1Cgrf/Oprm1tm1.1Cgrf Scn10atm2(cre)Jwo/Scn10a+
(involves: 129 * C57BL/6J)
|
abnormal behavioral response to addictive substance
|
J:207536
|
Oprm1tm1.1Jbwa/Oprm1tm1.1Jbwa
(involves: 129S6/SvEvTac * C57BL/6)
|
enhanced behavioral response to addictive substance
|
J:101977
|
Oprm1tm1Jabl/Oprm1tm1Jabl
(C57BL/6-Oprm1tm1Jabl)
|
impaired behavioral response to morphine
|
J:150840
|
Oprm1tm1Jep/Oprm1+
(involves: 129S/SvEv)
|
enhanced behavioral response to anesthetic
|
J:65217
|
impaired behavioral response to anesthetic
|
J:52952,
J:65217
|
impaired behavioral response to morphine
|
J:52952,
J:65217
|
Oprm1tm1Jep/Oprm1+
(B6.129S-Oprm1tm1Jep)
|
enhanced behavioral response to addictive substance
|
J:101294
|
Oprm1tm1Jep/Oprm1tm1Jep
(involves: 129S/SvEv)
|
enhanced behavioral response to anesthetic
|
J:65217
|
impaired behavioral response to anesthetic
|
J:52952,
J:65217
|
impaired behavioral response to morphine
|
J:52952,
J:65217
|
Oprm1tm1Jep/Oprm1tm1Jep
(B6.129S-Oprm1tm1Jep)
|
enhanced behavioral response to addictive substance
|
J:101294
|
Oprm1tm1Jlw/Oprm1tm1Jlw
(involves: 129P2/OlaHsd)
|
abnormal behavioral response to addictive substance
|
J:131412
|
Oprm1tm1Kff/Oprm1tm1Kff
(involves: 129S2/SvPas)
|
decreased behavioral withdrawal response
|
J:62551
|
impaired behavioral response to anesthetic
|
J:52952
|
impaired behavioral response to morphine
|
J:52952,
J:36241,
J:207536
|
Oprm1tm1Lex/Oprm1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6NTac)
|
impaired behavioral response to morphine
|
J:170718
|
Oprm1tm1Loh/Oprm1tm1Loh
(involves: 129P2/OlaHsd)
|
enhanced behavioral response to cocaine
|
J:107973
|
impaired behavioral response to morphine
|
J:47187,
J:107973
|
Oprm1tm1Lyu/Oprm1+
(involves: Black Swiss)
|
impaired behavioral response to morphine
|
J:39864
|
Oprm1tm1Lyu/Oprm1tm1Lyu
(involves: Black Swiss)
|
impaired behavioral response to morphine
|
J:39864
|
Oprm1tm1Shlz/Oprm1tm1Shlz
(involves: C57BL/6)
|
enhanced behavioral response to morphine
|
J:176122
|
Oprm1tm1Uhl/Oprm1tm1Uhl
(involves: 129S7/SvEvBrd * C57BL/6J)
|
impaired behavioral response to morphine
|
J:106256
|
P2rx6tm1Dgen/P2rx6tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased susceptibility to pharmacologically induced seizures
|
J:82809
|
Panx1tm1.1Fama/Panx1tm1.1Fama
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:177671
|
Panx1tm1a(KOMP)Wtsi/Panx1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased susceptibility to pharmacologically induced seizures
|
J:177671
|
Park7tm1Dsp/Park7tm1Dsp
(B6.129P2-Park7tm1Dsp)
|
abnormal behavioral response to xenobiotic
|
J:97366
|
Pbw1C57BL/6J/Pbw1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
decreased behavioral withdrawal response
|
J:54502
|
Pbw1DBA/2J/Pbw1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
decreased behavioral withdrawal response
|
J:54502
|
Pbw1DBA/2J/Pbw1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased behavioral withdrawal response
|
J:54502
|
Pbw2C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
decreased behavioral withdrawal response
|
J:76251
|
Pbw2C57BL/6J/Pbw2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
decreased behavioral withdrawal response
|
J:91275
|
Pbw2DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased behavioral withdrawal response
|
J:76251
|
Pbw3C57BL/6J/Pbw3C57BL/6J PbwmDBA/2J/PbwmDBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased behavioral withdrawal response
|
J:71080
|
Pbw3DBA/1J/Pbw3DBA/1J
(involves: DBA/1J * DBA/2J)
|
increased behavioral withdrawal response
|
J:98588
|
PbwmDBA/2J/PbwmDBA/2J
(involves: C57BL/6J * DBA/2J)
|
increased behavioral withdrawal response
|
J:71080
|
Pcmt1tm1Scl/Pcmt1tm1Scl
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:40967
|
Pcpila1C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to addictive substance
|
J:36714
|
Pcpila2C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to addictive substance
|
J:36714
|
Pcpila3C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to addictive substance
|
J:36714
|
Pde4dtm1Mct/Pde4dtm1Mct
(B6.129P2-Pde4dtm1Mct/Mmucd)
|
abnormal behavioral response to anesthetic
|
J:304450
|
Pde8atm1Dgen/Pde8atm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:82809
|
Pde11atm1Dgen/Pde11atm1Dgen
(involves: 129S/SvEv * C57BL/6)
|
enhanced behavioral response to xenobiotic
|
J:160319
|
Pdlim5Gt(XH199)Byg/Pdlim5+
(B6.129P2-Pdlim5Gt(XH199)Byg)
|
impaired behavioral response to addictive substance
|
J:200039
|
Pdyntm1(cre)Czer/Pdyn+
(B6.Cg-Pdyntm1(cre)Czer)
|
increased susceptibility to pharmacologically induced seizures
|
J:122651
|
Pdyntm1(cre)Czer/Pdyntm1(cre)Czer
(B6.Cg-Pdyntm1(cre)Czer)
|
increased susceptibility to pharmacologically induced seizures
|
J:122651
|
Penk-rstm1Pig/Penk-rstm1Pig
(B6.129-Penk-rstm1Pig)
|
decreased behavioral withdrawal response
|
J:66732
|
Penk-rstm1Pig/Penk-rstm1Pig
(B6.129-Penk-rstm1Pig/J)
|
decreased behavioral withdrawal response
|
J:98226
|
impaired behavioral response to nicotine
|
J:98226
|
Penktm1Jep/Penktm1Jep
(involves: 129S/SvEv * C57BL/6J)
|
abnormal behavioral response to addictive substance
|
J:109209
|
Per2tm1Brd/Per2tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
enhanced behavioral response to cocaine
|
J:77340
|
Phf6em1Azbi/Y
(B6.Cg-Phf6em1Azbi)
|
increased susceptibility to pharmacologically induced seizures
|
J:271089
|
Pianptm1d(KOMP)Wtsi/Pianptm1d(KOMP)Wtsi
(involves: BALB/cJ * C57BL/6N * SJL)
|
enhanced behavioral response to amphetamine
|
J:279537
|
Pis1A/J/Pis1A/J
(C57BL/6J-Chr 10A/J/NaJ)
|
increased susceptibility to pharmacologically induced seizures
|
J:118211
|
Pis2A/J/Pis2A/J
(C57BL/6J-Chr 18A/J/NaJ)
|
increased susceptibility to pharmacologically induced seizures
|
J:118211
|
Plattm1Mlg/Plattm1Mlg
(B6.Cg-Plattm1Mlg)
|
impaired behavioral response to morphine
|
J:88913
|
Plaurtm1Mlg/Plaurtm1Mlg
(B6.Cg-Plaurtm1Mlg)
|
increased susceptibility to pharmacologically induced seizures
|
J:81735
|
Plcb1tm1Hssh/Plcb1tm1Hssh
(Not Specified)
|
increased susceptibility to pharmacologically induced seizures
|
J:43077
|
Plcl1tm1Mh/Plcl1tm1Mh
(involves: C57BL/6)
|
impaired behavioral response to xenobiotic
|
J:92489
|
Plcl1tm1Mh/Plcl1tm1Mh
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:92956
|
Plppr5em2Gpt/Plppr5em2Gpt
(C57BL/6-Plppr5em2Gpt)
|
increased susceptibility to pharmacologically induced seizures
|
J:324004
|
Pnoctm1Jep/Pnoctm1Jep
(Not Specified)
|
enhanced behavioral response to xenobiotic
|
J:85899
|
Pomctm1Low/Pomctm1Low
(B6.129S2-Pomctm1Low)
|
abnormal alcohol consumption
|
J:49706
|
hyperactivity elicited by ethanol administration
|
J:49706
|
increased alcohol consumption
|
J:49706
|
Pomctm1Low/Pomctm1Low
(involves: 129S2/SvPas * C57BL/6N)
|
abnormal behavioral response to addictive substance
|
J:47711
|
Portm1Ding/Portm1Ding Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * C57BL/6 * DBA)
|
enhanced behavioral response to xenobiotic
|
J:84422
|
Portm3Ding/Portm3Ding
(C57BL/6-Portm3Ding)
|
enhanced behavioral response to anesthetic
|
J:159168
|
Ppargc1atm2.1Brsp/Ppargc1atm2.1Brsp
(involves: 129)
|
abnormal behavioral response to amphetamine
|
J:234906
|
Ppp1r1btm1Aaf/Ppp1r1btm1Aaf
(involves: 129P2/OlaHsd * C57BL/6J)
|
impaired behavioral response to addictive substance
|
J:78045
|
impaired behavioral response to cocaine
|
J:78045
|
Ppp1r1btm1Aaf/Ppp1r1btm1Aaf
(Not Specified)
|
enhanced behavioral response to cocaine
|
J:54156
|
Ppp1r1btm1Aaf/Ppp1r1btm1Aaf
(B6.129-Ppp1r1btm1Aaf)
|
abnormal alcohol consumption
|
J:66956
|
hyperactivity elicited by ethanol administration
|
J:66956
|
Ppp1r1btm1Aaf/Ppp1r1btm1Aaf
(B6.129P2-Ppp1r1btm1Aaf)
|
impaired behavioral response to addictive substance
|
J:107305
|
Ppp1r1btm1Pggd/Ppp1r1btm1Pggd
(involves: 129 * C57BL/6)
|
impaired behavioral response to addictive substance
|
J:107305
|
impaired behavioral response to cocaine
|
J:106270
|
Ppp1r1btm2Pggd/Ppp1r1btm2Pggd
(involves: 129 * C57BL/6)
|
impaired behavioral response to addictive substance
|
J:107305
|
Ppp1r1btm3Pggd/Ppp1r1btm3Pggd
(involves: 129 * C57BL/6)
|
impaired behavioral response to addictive substance
|
J:107305
|
impaired behavioral response to cocaine
|
J:106270
|
Ppp1r1btm4Pggd/Ppp1r1btm4Pggd
(Not Specified)
|
impaired behavioral response to cocaine
|
J:137074
|
impaired behavioral response to morphine
|
J:137074
|
Ppp1r1btm5.1Pggd/Ppp1r1btm5.1Pggd Tg(Drd1-cre)EY262Gsat/0 Tg(Drd1-EGFP)X60Gsat/0
(involves: C57BL/6 * FVB/N * FVB/NTac)
|
impaired behavioral response to cocaine
|
J:163700
|
impaired behavioral response to xenobiotic
|
J:163700
|
Ppp1r1btm5.1Pggd/Ppp1r1btm5.1Pggd Tg(Drd2-cre)ER44Gsat/0 Tg(Drd2-EGFP)S118Gsat/0
(involves: C57BL/6 * FVB/N * FVB/NTac)
|
enhanced behavioral response to cocaine
|
J:163700
|
impaired behavioral response to xenobiotic
|
J:163700
|
Ppp1r9atm1Pggd/Ppp1r9atm1Pggd
(involves: 129/SvEv * C57BL/6)
|
enhanced behavioral response to cocaine
|
J:110264
|
Ppp1r9btm1Jfe/Ppp1r9btm1Jfe
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:77284
|
enhanced behavioral response to cocaine
|
J:110264
|
Ppp1r14ctm1Uhl/Ppp1r14c+
(involves: 129S6/SvEvTac * C57BL/6J)
|
enhanced behavioral response to morphine
|
J:159561
|
Ppp1r14ctm1Uhl/Ppp1r14ctm1Uhl
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal behavioral response to addictive substance
|
J:159561
|
enhanced behavioral response to morphine
|
J:159561
|
Prickle1em1Yzou/Prickle1+
(C57BL/6-Prickle1em1Yzou)
|
increased susceptibility to pharmacologically induced seizures
|
J:321396
|
Prickle2tm1Nue/Prickle2tm1Nue
(B6.Cg-Prickle2tm1Nue)
|
increased susceptibility to pharmacologically induced seizures
|
J:169136
|
Prkaa2tm1Vio/Prkaa2tm1Vio Tg(Agrp-cre)1Gsb/0
(involves: 129S2/SvPas * FVB/N)
|
enhanced behavioral response to xenobiotic
|
J:123951
|
Prkar2btm1Gsm/Prkar2btm1Gsm
(involves: 129X1/SvJ * C57BL/6)
|
enhanced behavioral response to addictive substance
|
J:47453
|
Prkcetm1Msg/Prkcetm1Msg Tg(Prnp-tTA)F959Sbp/0 Tg(tetO-Prkce)T9Msg/0
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J * FVB/N)
|
decreased alcohol consumption
|
J:80186
|
Prkcgtm1Stl/Prkcgtm1Stl
(Not Specified)
|
impaired behavioral response to alcohol
|
J:25061
|
Prkcgtm1Stl/Prkcgtm1Stl
(involves: 129X1/SvJ * C57BL/6J)
|
enhanced behavioral response to alcohol
|
J:54243
|
Prkcgtm1Stl/Prkcgtm1Stl
(involves: 129S6/SvEvTac * C57BL/6J)
|
alcohol preference
|
J:79995
|
impaired behavioral response to alcohol
|
J:54243
|
Prkcgtm1Stl/Prkcgtm1Stl
(B6.129-Prkcgtm1Stl)
|
enhanced behavioral response to alcohol
|
J:54243
|
Prkntm1Ccs/Prkntm1Ccs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired behavioral response to xenobiotic
|
J:127250
|
Prlhrtm1Map/Prlhrtm1Map
(involves: 129S6/SvEvTac * CD-1)
|
decreased behavioral withdrawal response
|
J:103932
|
Prrt2tm1a(KOMP)Wtsi/Prrt2tm1a(KOMP)Wtsi
(C57BL/6N-Atm1Brd Prrt2tm1a(KOMP)Wtsi/Wtsi)
|
increased susceptibility to pharmacologically induced seizures
|
J:237823
|
Psmc5tm1.1Itl/Psmc5tm1.1Itl
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal sensitization to xenobiotic
|
J:260973
|
impaired behavioral response to cocaine
|
J:260973
|
Ptentm1Hwu/Ptentm1Hwu Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal behavioral response to xenobiotic
|
J:153622
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac)
|
increased susceptibility to pharmacologically induced seizures
|
J:141610
|
Ptprotm1Dgen/Ptprotm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Rbfox1tm1.1Dblk/Rbfox1+ Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to pharmacologically induced seizures
|
J:176189
|
Rbfox1tm1.1Dblk/Rbfox1tm1.1Dblk Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to pharmacologically induced seizures
|
J:176189
|
Rbfox3tm1a(EUCOMM)Hmgu/Rbfox3tm1a(EUCOMM)Hmgu
(B6Dnk;B6N-Rbfox3tm1a(EUCOMM)Hmgu/H)
|
increased susceptibility to pharmacologically induced seizures
|
J:234043
|
Rgs4tm1.1Jbr/Rgs4tm1.1Jbr
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased behavioral withdrawal response
|
J:98888
|
impaired behavioral response to morphine
|
J:98888
|
Rogditm1.2Ics/Rogditm1.2Ics
(involves: C57BL/6N)
|
increased susceptibility to pharmacologically induced seizures
|
J:344072
|
Rps6ka5tm1Jsca/Rps6ka5tm1Jsca
(B6.Cg-Rps6ka5tm1Jsca)
|
impaired behavioral response to cocaine
|
J:123042
|
Rr364729em1Almk/Rr364729em1Almk
(C57BL/6-Rr364729em1Almk)
|
low alcohol preference
|
J:334339
|
Ryr1tm1Slh/Ryr1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
enhanced behavioral response to xenobiotic
|
J:105738
|
Ryr2tm1Slh/Ryr2+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:235432
|
Ryr2tm2Amks/Ryr2+
(B6.129-Ryr2tm2Amks)
|
increased susceptibility to pharmacologically induced seizures
|
J:137696
|
Ryr2tm2Amks/Ryr2tm2Amks
(B6.129-Ryr2tm2Amks)
|
increased susceptibility to pharmacologically induced seizures
|
J:137696
|
S100a10tm1Pggd/S100a10tm1Pggd
(involves: 129S/SvEv * C57BL/6)
|
impaired behavioral response to xenobiotic
|
J:131963,
J:104116
|
Scn1aem1Anord/Scn1a+
(C57BL/6N-Scn1aem1Anord)
|
increased susceptibility to pharmacologically induced seizures
|
J:333350
|
Scn1atm1.1Aesc/Scn1a+
(involves: 129X1/SvJ * C57BL/6J * SJL)
|
increased susceptibility to pharmacologically induced seizures
|
J:161191
|
Scn1atm1.1Aesc/Scn1a+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:170734
|
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:209093
|
Scn1atm1Wac/Scn1a+
(involves: 129S1/Sv * 129X1/SvJ * FVB/NJ)
|
increased susceptibility to pharmacologically induced seizures
|
J:129998
|
Scn2btm1Isom/Scn2btm1Isom
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:82050
|
Scn4btm1.2Geh/Scn4btm1.2Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
impaired behavioral response to amphetamine
|
J:261348
|
Scn8aClth/Scn8aClth
(involves: BALB/cAnN * C3H/HeH)
|
enhanced behavioral response to anesthetic
|
J:155726
|
Scn8amed-jo/Scn8a+
(B6.D2-Scn8amed-jo/J)
|
decreased susceptibility to pharmacologically induced seizures
|
J:170734,
J:129998
|
Scn8amed/Scn8a+
(C3Fe.Cg-Scn8amed/J)
|
decreased susceptibility to pharmacologically induced seizures
|
J:129998
|
Serpina6tm1.1Mmp/Serpina6tm1.1Mmp
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
impaired behavioral response to cocaine
|
J:164345
|
Serpine2tm1Dmn/Serpine2tm1Dmn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:40953
|
Sez6tm1.1Sest/Sez6tm1.1Sest
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased susceptibility to pharmacologically induced seizures
|
J:132725
|
Sh3kbp1tm1Ivdi/Sh3kbp1tm1Ivdi
(B6.129S-Sh3kbp1tm1Ivdi)
|
abnormal behavioral response to xenobiotic
|
J:162088
|
Shank3tm1.1Cya/Shank3tm1.1Cya
(B6.Cg-Shank3tm1.1Cya)
|
decreased susceptibility to pharmacologically induced seizures
|
J:281328
|
Sicd1C57BL/6J/Sicd1C57BL/6J
(FVB.B6-(D18Mit141-D18Mit25))
|
increased susceptibility to pharmacologically induced seizures
|
J:122922
|
Sipa1l1tm1Taki/Sipa1l1tm1Taki
(B6.Cg-Sipa1l1tm1Taki/Taki)
|
abnormal behavioral response to xenobiotic
|
J:345320
|
enhanced behavioral response to xenobiotic
|
J:345320
|
impaired behavioral response to xenobiotic
|
J:345320
|
increased susceptibility to pharmacologically induced seizures
|
J:345320
|
Skap2Gt(VICTR20)21Lex/Skap2Gt(VICTR20)21Lex
(B6.129S5-Skap2Gt(VICTR20)21Lex)
|
abnormal behavioral response to addictive substance
|
J:216839
|
Slc1a2tm1Kta/Slc1a2tm1Kta
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:40984
|
Slc1a3tm1Kta/Slc1a3tm1Kta
(involves: 129P2/OlaHsd)
|
increased susceptibility to pharmacologically induced seizures
|
J:58180
|
Slc4a3tm1Cahb/Slc4a3tm1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:104157
|
Slc4a10tm1.1Cahb/Slc4a10tm1.1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:131058
|
Slc6a1tm1Mlit/Slc6a1+
(involves: 129S1/Sv * C57BL/6)
|
alcohol preference
|
J:144919
|
hyperactivity elicited by ethanol administration
|
J:144919
|
increased alcohol consumption
|
J:144919
|
Slc6a1tm1Mlit/Slc6a1tm1Mlit
(involves: 129S1/Sv * C57BL/6)
|
abnormal behavioral response to xenobiotic
|
J:144919
|
Slc6a1tm1Mlit/Slc6a1tm1Mlit
(B6.129S1-Slc6a1tm1Mlit)
|
enhanced behavioral response to xenobiotic
|
J:204368
|
Slc6a2tm1.1Hhg/Slc6a2tm1.1Hhg
(B6.129P2(Cg)-Slc6a2tm1.1Hhg)
|
impaired behavioral response to cocaine
|
J:101977
|
impaired behavioral response to xenobiotic
|
J:101977
|
Slc6a2tm1Mca/Slc6a2tm1Mca
(involves: 129S4/SvJaeSor * C57BL/6J)
|
enhanced behavioral response to addictive substance
|
J:61825
|
enhanced behavioral response to cocaine
|
J:61825
|
Slc6a3tm1Rbl/Slc6a3tm1Rbl
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal behavioral response to xenobiotic
|
J:216661
|
Slc6a4tm1.1Rbl/Slc6a4tm1.1Rbl
(129S6/SvEvTac-Slc6a4tm1.1Rbl)
|
impaired behavioral response to xenobiotic
|
J:170356
|
Slc6a4tm2.1Rbl/Slc6a4tm2.1Rbl
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
enhanced behavioral response to xenobiotic
|
J:202876
|
Slc6a9tm1.1Bois/Slc6a9tm1.1Bois Tg(Camk2a-cre)2834Lusc/0
(involves: C57BL/6J)
|
impaired behavioral response to addictive substance
|
J:106967
|
Slc6a11tm1Dgen/Slc6a11+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:101679
|
Slc7a8tm1Dgen/Slc7a8tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:101679
|
Slc9a6tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Slc10a4tm1Tigm/Slc10a4tm1Tigm
(involves: 129S/SvEvBrd)
|
increased susceptibility to pharmacologically induced seizures
|
J:196996
|
Slc12a5tm1Dlp/Slc12a5+
(involves: C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:113307
|
Slc12a5tm1Hsav/Slc12a5tm2Hsav
(involves: 129S1/Sv * 129S2/SvPasHsd * 129X1/SvJ * C57BL/6J * C57BL/6JOlaHsd)
|
increased susceptibility to pharmacologically induced seizures
|
J:101079
|
Slc12a6tm1Tjj/Slc12a6tm1Tjj
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:86183
|
Slc17a6tm1.1Thna/Slc17a6tm1.1Thna Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+ Slc6a3tm1(cre)Xz/Slc6a3+
(involves: 129/Sv * 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J)
|
impaired behavioral response to cocaine
|
J:167767
|
Slc17a8tm1Selm/Slc17a8tm1Selm
(involves: 129/Sv * C57BL/6)
|
enhanced behavioral response to cocaine
|
J:135586
|
impaired behavioral response to xenobiotic
|
J:135586
|
Slc18a2tm1Mca/Slc18a2+
(involves: 129X1/SvJ)
|
enhanced behavioral response to addictive substance
|
J:45184
|
impaired behavioral response to cocaine
|
J:45184
|
Slc18a2tm1Mca/Slc18a2+
(involves: 129X1/SvJ * C57BL/6J)
|
decreased alcohol consumption
|
J:124481
|
Slc18a2tm1Uhl/Slc18a2+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
enhanced behavioral response to addictive substance
|
J:42811
|
Slc18a3tm1Mca/Slc18a3tm1Mca
(involves: 129S4/SvJae * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:136620
|
Slc18b1tm1.1Ubc/Slc18b1tm1.1Ubc Tg(Pgk1-cre)1Lni/0
(involves: 129 * BALB/c * C57BL/6 * SJL)
|
enhanced behavioral response to amphetamine
|
J:282689
|
impaired behavioral response to addictive substance
|
J:282689
|
Slc25a12Gt(OST123999)Lex/Slc25a12+
(involves: 129S5/SvEvBrd * C57BL/6)
|
enhanced behavioral response to amphetamine
|
J:193095
|
Slc29a1tm1Msg/Slc29a1tm1Msg
(involves: 129X1/SvJ * C57BL/6J)
|
alcohol preference
|
J:92100
|
impaired behavioral response to alcohol
|
J:92100
|
increased alcohol consumption
|
J:92100
|
Slitrk3tm1Jaru/Slitrk3tm1Jaru
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:232385
|
Slitrk5tm2Vlcg/Slitrk5tm2Vlcg
(involves: 129S/Sv * C57BL/6)
|
enhanced behavioral response to xenobiotic
|
J:160616
|
Slms1C57BL/6J/Slms1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
hyperactivity elicited by ethanol administration
|
J:114156
|
Slms1DBA/2J/Slms1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
hyperactivity elicited by ethanol administration
|
J:114156
|
Slms2C57BL/6J/Slms2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to xenobiotic
|
J:114156
|
hyperactivity elicited by ethanol administration
|
J:114156
|
Slms2DBA/2J/Slms2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to xenobiotic
|
J:114156
|
hyperactivity elicited by ethanol administration
|
J:114156
|
Sod1tm1Ysh/Sod1tm1Ysh
(involves: 129X1/SvJ * C57BL/6)
|
enhanced behavioral response to xenobiotic
|
J:46672
|
Sorcs2tm1Anyk/Sorcs2tm1Anyk
(B6.129-Sorcs2tm1Anyk)
|
abnormal behavioral response to addictive substance
|
J:214739
|
Stamtm1Sug/Stamtm1Sug
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:69504
|
Syngap1tm1Rlh/Syngap1+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to pharmacologically induced seizures
|
J:193208
|
Szs1C57BL/6J/Szs1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:56630
|
Szs1DBA/2J/Szs1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:56630
|
Szs5DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:56630
|
Szs6C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:56630
|
Szt1/Szt1+
(involves: BALB/cByJ * BALB/cJ * C57BL/6J)
|
abnormal seizure response to pharmacological agent
|
J:82964
|
Szt2m1Frk/Szt2m1Frk
(involves: BALB/cByJ * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:150942
|
Szv1C57BL/6J/Szv1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:38888
|
Szv2C57BL/6J/Szv2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:38888
|
Szv2C57BL/6J/Szv2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:38888
|
Szv3C57BL/6J/Szv3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:70295
|
Szv3DBA/2J/Szv3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:70295
|
Taar1em1Ejc/Taar1em1Ejc
(C57BL/6J-Taar1em1Ejc/Ejc)
|
high preference for an addictive substance
|
J:310042
|
Taar1em2Ejc/Taar1em2Ejc
(DBA/2J-Taar1em2Ejc/Ejc)
|
abnormal behavioral response to methamphetamine
|
J:310042
|
Taar1m1J/Taar1m1J
(DBA/2J)
|
enhanced behavioral response to addictive substance
|
J:224677
|
Taar1m1J/Taar1m1J
(involves: C57BL/6J * DBA/2J)
|
enhanced behavioral response to addictive substance
|
J:224677
|
Taar1tm1(KOMP)Vlcg/Taar1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
enhanced behavioral response to addictive substance
|
J:224677
|
Taar1tm1Tdw/Taar1tm1Tdw
(involves: 129S1/Sv * C57BL/6J)
|
enhanced behavioral response to addictive substance
|
J:141501
|
Tacr1tm1Rhn/Tacr1tm1Rhn
(129S/SvEv-Tacr1tm1Rhn)
|
impaired behavioral response to xenobiotic
|
J:77640
|
Tacr1tm1Sph/Tacr1tm1Sph
(involves: 129P2/OlaHsd)
|
impaired behavioral response to addictive substance
|
J:171881
|
impaired behavioral response to morphine
|
J:171881
|
Tamalintm1.1Nak/Tamalintm1.1Nak
(B6.129S-Tamalintm1.1Nak)
|
impaired behavioral response to morphine
|
J:124994
|
Taok2tm1.1Dkap/Taok2tm1.1Dkap Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6NTac * SJL)
|
enhanced behavioral response to alcohol
|
J:206781
|
increased alcohol consumption
|
J:206781
|
Taok2tm1.2Dkap/Taok2tm1.2Dkap
(B6(Cg)-Taok2tm1.2Dkap)
|
impaired behavioral response to alcohol
|
J:206781
|
increased alcohol consumption
|
J:206781
|
Taok3Gt(RRK451)Byg/Taok3+
(B6.129P2-Taok3Gt(RRK451)Byg)
|
impaired behavioral response to alcohol
|
J:195683
|
Tg(ACTB-APP*V717F)1Colm/0
(involves: C57BL/6 * DBA)
|
enhanced behavioral response to addictive substance
|
J:157859
|
Tg(Adora2a-Chrm3*,-mCherry)AD6Blr/?
(involves: C57BL/6J * SJL/J)
|
impaired behavioral response to addictive substance
|
J:191042
|
Tg(Camk2a-DISC1)10Asaw/0
(C57BL/6-Tg(Camk2a-DISC1)10Asaw)
|
enhanced behavioral response to addictive substance
|
J:194985
|
Tg(Camk2a-DISC1)37Asaw/0
(C57BL/6-Tg(Camk2a-DISC1)37Asaw)
|
enhanced behavioral response to addictive substance
|
J:194985
|
Tg(Camk2a-Fyn-531)1Nko/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
increased susceptibility to pharmacologically induced seizures
|
J:59490
|
Tg(Camk2a-Fyn-531)1Nko/0
(B6.Cg-Tg(Camk2a-Fyn-531)1Nko)
|
alcohol aversion
|
J:79980
|
decreased behavioral withdrawal response
|
J:79980
|
impaired behavioral response to alcohol
|
J:79980
|
Tg(Camk2a-Prkaca)426Tabe/0
(involves: C57BL/6J * CBA/J)
|
decreased alcohol consumption
|
J:70175
|
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-Csnk1d)#Mfla/0
(involves: 129/Sv * C57BL/6)
|
abnormal behavioral response to xenobiotic
|
J:158611
|
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-MAPT)32Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT)32Lms)
|
increased susceptibility to pharmacologically induced seizures
|
J:233816
|
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-MAPT*A152T)L1Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT*A152T)L1Lms)
|
increased susceptibility to pharmacologically induced seizures
|
J:233816
|
Tg(Cck-EGFP/RNAi:Gad1)2Mirn/?
(C57BL/6NHsd-Tg(Cck-EGFP/RNAi:Gad1)2Mirn)
|
abnormal behavioral response to amphetamine
|
J:227900
|
Tg(Chat-COP4*H134R/EYFP,Slc18a3)6Gfng/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
enhanced behavioral response to addictive substance
|
J:213335
|
Tg(Cnr1-EGFP/RNAi:Gad1)1Mirn/?
(C57BL/6-Tg(Cnr1-EGFP/RNAi:Gad1)1Mirn)
|
abnormal behavioral response to amphetamine
|
J:210380
|
Tg(DBH-Gal)1923Stei/0
(B6.Cg-Tg(DBH-Gal)1923Stei)
|
decreased susceptibility to pharmacologically induced seizures
|
J:77625
|
Tg(GFAP-EFNA3)181Kln/0
(involves: C57BL/6 * FVB)
|
increased susceptibility to pharmacologically induced seizures
|
J:154648
|
Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:139349
|
Tg(GFAP-tTA)110Pop/0 Tg(tetO-DISC1*)1302BPlet/0
(B6.Cg-Tg(GFAP-tTA)110Pop Tg(tetO-DISC1*)1302BPlet)
|
enhanced behavioral response to xenobiotic
|
J:244437
|
Tg(Lgi1*)#Mpan/0
(Not Specified)
|
increased susceptibility to pharmacologically induced seizures
|
J:154129
|
Tg(Lmnb1)1Yfu/0
(involves: C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:197168
|
Tg(Mpdz)1Kb/0
(involves: C57BL/6 * DBA/2)
|
decreased behavioral withdrawal response
|
J:226456
|
Tg(Npy-EGFP/RNAi:Gad1)1Mirn/?
(C57BL/6NHsd-Tg(Npy-EGFP/RNAi:Gad1)1Mirn)
|
abnormal behavioral response to amphetamine
|
J:227900
|
Tg(PGK1-FTL*)#Sle/0
(involves: FVB/N)
|
abnormal behavioral response to xenobiotic
|
J:226967
|
Tg(Plp1-HTT*150Q)4aXjl/0
(Not Specified)
|
increased susceptibility to pharmacologically induced seizures
|
J:221608
|
Tg(Pnkd*A7V*A9V,-DsRed)671Ljp/0
(B6.Cg-Tg(Pnkd*A7V*A9V,-DsRed)671Ljp)
|
abnormal behavioral response to xenobiotic
|
J:192798
|
Tg(Pnkd*A7V*A9V,-DsRed)704Ljp/0
(B6.Cg-Tg(Pnkd*A7V*A9V,-DsRed)704Ljp)
|
abnormal behavioral response to xenobiotic
|
J:192798
|
Tg(Prnp-lacZ/ATXN10*)#Teas/0
(involves: FVB/N)
|
increased susceptibility to pharmacologically induced seizures
|
J:222081
|
Tg(RP11-111A8)1Zim/0
(involves: CD-1)
|
enhanced behavioral response to addictive substance
|
J:150615
|
Tg(Scn1a*)RH9Aesc/0
(involves: FVB/NJ)
|
increased susceptibility to pharmacologically induced seizures
|
J:150454
|
Tg(Syn1-ADCY7)11004Btab/0
(involves: C57BL/6 * SJL)
|
abnormal behavioral response to xenobiotic
|
J:116797
|
Tg(Thy1-App*R609D*K612E)4Vln/Tg(Thy1-App*R609D*K612E)4Vln
(involves: FVB)
|
decreased susceptibility to pharmacologically induced seizures
|
J:32213
|
increased susceptibility to pharmacologically induced seizures
|
J:32213
|
Tg(Thy1-App*R609D*K612E)6Vln/Tg(Thy1-App*R609D*K612E)6Vln
(involves: FVB)
|
decreased susceptibility to pharmacologically induced seizures
|
J:32213
|
increased susceptibility to pharmacologically induced seizures
|
J:32213
|
Tg(Thy1-MAPT*)1Avil/Tg(Thy1-MAPT*)1Avil
(involves: C57BL/6 * CBA)
|
increased susceptibility to pharmacologically induced seizures
|
J:201700
|
Tg(Thy1-MAPT*K369I)K3Gotz/0
(B6.Cg-Tg(Thy1-MAPT*K369I)K3Gotz)
|
enhanced behavioral response to xenobiotic
|
J:143439
|
Tg(Thy1-SERPINI1*G392E)333Icka/0
(involves: C57BL * CD-1 * DBA)
|
increased susceptibility to pharmacologically induced seizures
|
J:144649
|
Tg(Thy1-SERPINI1*G392E)333Icka/Tg(Thy1-SERPINI1*G392E)333Icka
(involves: C57BL * CD-1 * DBA)
|
increased susceptibility to pharmacologically induced seizures
|
J:144649
|
Tg(UBC-Adk)1Bois/0
(B6;129P3-Adktm1Bois Tg(UBC-Adk)1Bois)
|
abnormal seizure response to pharmacological agent
|
J:105483
|
tmgc12/tmgc12
(involves: C3H/Rl * C57BL/6)
|
hyperactivity elicited by ethanol administration
|
J:81149
|
tmgc12/tmgc12
(involves: C3H * C57BL/6 * C57BL/6J)
|
hyperactivity elicited by ethanol administration
|
J:136464
|
tmgc20/tmgc20
(involves: C3H/Rl * C57BL/6)
|
hyperactivity elicited by ethanol administration
|
J:81149
|
tmgc35/tmgc35
(involves: C3H/Rl * C57BL/6JRn)
|
impaired behavioral response to cocaine
|
J:92490
|
tmgc43/tmgc43
(Mixed stock)
|
impaired behavioral response to cocaine
|
J:92490
|
tmgc49/tmgc49
(mixed)
|
alcohol preference
|
J:92490
|
increased alcohol consumption
|
J:92490
|
tmgc50/tmgc50
(involves: C3H/Rl * C3Hf/HeA * C57BL/6JRn * C57BL/LiA)
|
increased alcohol consumption
|
J:92490
|
tmgc55/tmgc55
(C57BL/6-Chr 19PWK tmgc55)
|
alcohol preference
|
J:92490
|
decreased alcohol consumption
|
J:92490
|
tmgc61/tmgc61
(Mixed stock)
|
decreased susceptibility to pharmacologically induced seizures
|
J:92490
|
Trim3tm1Mak/Trim3tm1Mak
(B6.129P2-Trim3tm1Mak)
|
decreased susceptibility to pharmacologically induced seizures
|
J:161372
|
Trpc5tm1.1Lbi/Y
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased susceptibility to pharmacologically induced seizures
|
J:194590
|
Trpc5tm1.1Lbi/Trpc5tm1.1Lbi
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased susceptibility to pharmacologically induced seizures
|
J:194590
|
Trpm2tm1Yamo/Trpm2tm1Yamo
(B6J.129S4-Trpm2tm1Yamo)
|
abnormal behavioral response to xenobiotic
|
J:226171
|
Trpv1tm1Jul/Trpv1tm1Jul
(B6.129X1-Trpv1tm1Jul/J)
|
alcohol preference
|
J:153529
|
impaired behavioral response to alcohol
|
J:153529
|
increased alcohol consumption
|
J:153529
|
Ttll1tm1Seto/Ttll1+ Ttll7tm1Seto/Ttll7tm1Seto
(involves: 129 * 129S/SvEv * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:345300
|
Tubg1tm1.1Ics/Tubg1+
(involves: C57BL/6N)
|
increased susceptibility to pharmacologically induced seizures
|
J:275532
|
Unc79Lwt/Unc79+
(B6.D2-Unc79Lwt)
|
alcohol preference
|
J:163308
|
enhanced behavioral response to alcohol
|
J:163308
|
impaired behavioral response to anesthetic
|
J:163308
|
increased alcohol consumption
|
J:163308
|
Upp1tm1Gp/Upp1tm1Gp
(involves: 129)
|
impaired behavioral response to xenobiotic
|
J:99912
|
Vacq1C57BL/6J/Vacq1C57BL/6J
(involves: A/J * C57BL/6J)
|
alcohol preference
|
J:100637
|
increased alcohol consumption
|
J:100637
|
Vacq1C57BL/6J/Vacq1C57BL/6J Vacq2C57BL/6J/Vacq2C57BL/6J
(involves: A/J * C57BL/6J)
|
alcohol preference
|
J:100637
|
increased alcohol consumption
|
J:100637
|
Vacq3C57BL/6J/Vacq3C57BL/6J
(involves: A/J * C57BL/6J)
|
alcohol preference
|
J:100637
|
increased alcohol consumption
|
J:100637
|
Vacq4A/J/Vacq4A/J
(involves: A/J * C57BL/6J)
|
alcohol preference
|
J:100637
|
increased alcohol consumption
|
J:100637
|
Vacq5C57BL/6J/Vacq5C57BL/6J
(involves: A/J * C57BL/6J)
|
alcohol preference
|
J:100637
|
increased alcohol consumption
|
J:100637
|
Vacq6A/J/Vacq6A/J
(involves: A/J * C57BL/6J)
|
alcohol preference
|
J:100637
|
increased alcohol consumption
|
J:100637
|
Vacq7A/J/Vacq7A/J
(involves: A/J * C57BL/6J)
|
alcohol preference
|
J:100637
|
increased alcohol consumption
|
J:100637
|
Wfs1tm1Koks/Wfs1+
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired behavioral response to addictive substance
|
J:145548
|
Wfs1tm1Koks/Wfs1tm1Koks
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal behavioral response to addictive substance
|
J:145548
|
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to pharmacologically induced seizures
|
J:121330
|
Zolw1DBA/1J/Zolw1DBA/1J
(involves: DBA/1J * DBA/2J)
|
increased behavioral withdrawal response
|
J:98588
|
Zswim6tm1.2Itl/Zswim6tm1.2Itl
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * C57BL/6NTac)
|
abnormal behavioral response to amphetamine
|
J:259070
|